Hossein Jadvar, MD, PhD, MPH, MBA, FACNM

 

     

Description: Description: Description: Description: Description: Description: Description: Description: Description: Description: USC formallogo_equation.png


      Associate Professor of Radiology

Associate Professor of Biomedical Engineering
Keck School of Medicine of USC

      University of Southern California      
     2250 Alcazar Street, CSC 102
      Los Angeles, California 90033 USA
      Tel: (323) 442-1107, Fax : (323) 442-3253
      E-mail: jadvar@med.usc.edu

Description: Description: Description: Description: Description: Description: Description: Description: Description: Description: jadvar1

Description: Description: Description: Description: Description: Description: Description: Description: Description: Description: logo_snmmi.gif 

 

Description: Description: Description: Description: Description: Description: Description: Description: Description: Description: ACNM logo.jpg


President-Elect, Society of Nuclear Medicine and Molecular Imaging

President, SNMMI PET Center of Excellence

Immediate Past President, American College of Nuclear Medicine


EDUCATION


B.S.

Chemical Engineering

Iowa State University, Ames, IA

1982 

M.S.

Biomedical Engineering

University of Wisconsin, Madison, WI

1984

M.S.E.

Computer, Information & Control Engineering

University of Michigan, Ann Arbor, MI

1986

Ph.D.

Bioengineering

University of Michigan, Ann Arbor, MI

1988

M.D.

Medicine

University of Chicago (Pritzker), Chicago, IL

1993

Internship

Internal Medicine

University of California, San Francisco (UCSF), San Francisco, CA

1993-1994

Residency

Diagnostic Radiology & Nuclear Medicine

Stanford University, Stanford, CA

1994-1998

Fellowship

PET, Oncologic & Pediatric Nuclear Medicine

Harvard Medical School, Boston, MA

1998-1999

M.P.H.

Public Health

Harvard University, Cambridge, MA

2005

M.B.A.

Business Administration (Executive)

University of Southern California (Marshall), Los Angeles, CA

2007


EXECUTIVE EDUCATION


Certificate

Clinical Effectiveness

Harvard Medical School, Boston, MA

2003

Certificate

Renaissance and the Scientific Revolution

University of Cambridge, Cambridge, UK

2007

Certificate

Colleges of Oxford

University of Oxford, Oxford, UK

2008

Certificate

Leadership

University of Pennsylvania (Wharton), Philadelphia, PA

2009


PROFESSIONAL CERTIFICATIONS & MEDICAL LICENSE


Medical License, California (1994-present)
Diplomat, National Board of Medical Examiners (NBME) (1994)
Diplomat, American Board of Nuclear Medicine (ABNM) (1998-present)
Diplomat, Certification Board of Nuclear Cardiology (CBNC) (1999-present)


HONORS & AWARDS


Dean's Honor List, Iowa State University (March 1979, June 1981, Feb 1982)

Tau Beta Pi, National Engineering Honor Society (April 1985)

Eta Kappa Nu, National Electrical Engineering Honor Society (April 1986)

Sigma Xi, Scientific Research Honor Society (April 1986)

Honorable Mention, Young Investigator Paper Competition, Engineering Foundation Computerized Interpretation of the Electrocardiogram XII, Palm Coast, Florida (April 1987)

Medical Student Summer Research Award, University of Chicago (January 1991)

Honors, Medicine and Psychiatry Junior Clerkships, University of Chicago (1992)

Biographee, Marquis Who's Who in America, Who's Who in American Education, Who's Who in Medicine and Health Care, Who's Who in Science and Engineering, Who's Who in the West, Who's Who in the World (1992-present);  Outstanding Young Men of America (1996-present), RR Bowker's American Men and Women of Science (1998), Strathmore's Who's Who (2000-2002), International Biographical Center (Cambridge, England) 2000 Outstanding Intellectuals of the 21st Century and the 21st Century Award for Achievement (2001) and International Scientist of the Year (2002)

Medical Alumni Prize, Best Oral Presentation at the 47th Annual Senior Scientific Session of research done in medical school, Pritzker School of Medicine, University of Chicago (June 1993)(See Publication List)

NIH Resident Research Award, Clinical Trainees Program for Distinguished Accomplishments in the Biomedical Sciences, Office of Education, National Institutes of Health Research Festival, Bethesda, Maryland. (New Engl J Med, Vol. 331, No. 23, December 8, 1994)(See Publication List)

Chief Resident in Nuclear Medicine, Stanford University School of Medicine, Stanford, CA (July 1, 1997-June 30, 1998)

RSNA Roentgen Resident/Fellow Research Award, Radiological Society of North America Research & Education Fund (1997 Progress Report, Page 10, in Radiology, Vol. 205, No. 3, December 1997)

ACNP Resident Research Competition Award, American College of Nuclear Physicians 24th Annual Meeting & Scientific Sessions, Las Vegas, NV (1998)(See Publication List)

SNM-1998 Featured Research, Official Conference Press Release (Nuclear Medicine and Women's Health) of the Society of Nuclear Medicine 45th Annual Meeting, Toronto, Ontario, Canada (1993)(See Publication List)

1999 Year Book of Nuclear Medicine Research Article Citation (Gottschalk A, Balufox MD, Coleman RE, Strauss HW, Zubal IG (eds.), Mosby Inc., St. Louis, MO, Chapter 5, pp. 207-208, ISBN 0-8151-3822-9)(See Publication List)

Aerospace Medicine Young Investigator Award Nominee, Aerospace Medical Association (Aviat Space Environ Med, Vol.71, No. 8, Page 875, August 2000)(See Publication List)

SNM Marc Tetalman Young Investigator Award, Education and Research Foundation, Society of Nuclear Medicine (for work accomplished by a young investigator based on research accomplishments, teaching ,clinical service, administration, service to the Society and a commitment to academic nuclear medicine)(J Nucl Med, Vol. 41, No. 9, Page 18N; September 2000, and USC HSC Weekly, Vol. 6, No. 20; June 23, 2000) [JNM Newsline Online: page 6] [USC HSC Weekly Online]

RSNA-2000 Featured Research, "In Review: News From the 2000 Meeting of the RSNA", by C. Kaiser. (Diagnostic Imaging (Suppl.): 46-47, January 2001)(See Publication List)

RSNA-2001 Featured Research, "PET scans help doctors better evaluate women with cervical cancer", by A. Di Rado. (USC HSC Weekly, Vol. 21, No. 35; December 14, 2001, and USC Chronicle, Vol. 21, Issue 17; February 4, 2002)(See Publication List) [USC HSC Weekly Online] [USC Chronicle Online]

RSNA-2002 Featured Research, "PET/CT proves its value in ovarian and prostate cancers", by H. Abella. (Diagnostic Imaging WebCast )(See Publication List)

RSNA-2002 Electronic Education Exhibit Certificate of Merit, "Coincidence imaging with modified gamma cameras: physical principles and clinical utility" (Radiology 225(P): 678; 2002)(See Publication List)

Fellow, American College of Nuclear Medicine (2003)

Fellow, American College of Nuclear Physicians (2005)

Bestseller Book, "Clinical PET and PET-CT (with JA Parker), Springer-Verlag, Inc., London, UK ", European Association of Nuclear Medicine Annual Congress, Istanbul, Turkey (2005)

Senior Member, Institute of Electrical and Electronics Engineers-Engineering in Medicine and Biology Society (IEEE-EMBS)(2006) -- ("for professional maturity and significant professional achievement"; as of January 2006, about 7.6% of IEEE members hold the Senior Member grade)

USC CER Faculty Fellow, Center for Excellence in Research, University of Southern California (2007-2010)

NIH-NCI Medical Imaging (MEDI) Review Panel Charter Member (2007-2011)

America's Top Radiologists, Consumers' Research Council of America, Washington, DC (2007)

 

Research Article Highlighted on Journal Cover (International Journal of Clinical Oncology -  Official Journal of the Japan Society of Clinical Oncology - see Publications – Journal Articles No. 39)(2008)

 

Invited Guest Editor, Molecular Imaging of Prostate Cancer, PET Clinics (2009)

SNM-2009 Featured Research, "PET/CT with FDG in metastatic prostate cancer: castrate-sensitive vs. castrate-resistant disease", by L. Gagnon. (WebMD/Medscape)(See Publication List)

San Gabriel Valley Top Doctors, Pasadena Magazine (2010, 2012, 2013, 2014)

Distinguished Scientist Award, 35th Annual Western Regional Society of Nuclear Medicine (WRSNM) Meeting, Anaheim, CA (2010) 

Best Doctors in America, (2011, 2012, 2013, 2014)

Editor’s Recognition Award (with Distinction), Radiology, H. Kressel, MD, Editor (Radiology 2011; 258:10-11)

 

Invited Guest Editor, Molecular Imaging Guided Diagnosis and Therapy of Prostate Cancer, Theranostics (2011)

 

Journal Editorial Leadership, Clinical Nuclear Medicine (Deputy Editor 2007-); American Journal of Roentgenology (Assistant Editor 2008-); Radiology (Associate Editor 2011-)

 

Top 25 Most Read Article (Journal of Nuclear Medicine – Official Journal of the Society of Nuclear Medicine, Impact Factor 7.022, journal ranked 1 of 111 imaging journals– see Publications – Journal Article No. 51)(June 2011)

 

SNM-2011 Featured Research (2011 SNM Highlights Lecture – Oncology; by SM Larson, MD; Journal of Nuclear Medicine 2011 52(Suppl 1):18N)

 

Top 10 Viewed Webcast of USC Keck School of Medicine Research Seminar Series (2011)

 

SNM-2012 Invited Speaker, Integrated Session: Translational Prostate Cancer Imaging (2012)

SNM-2012 3rd Place Top Educational Exhibit Poster, SNM 59th Ann Meeting, Miami Beach, FL (2012) (See Publication List)

ACNM Service Recognition as President 2013-2014, “In recognition and appreciation for your dedication, hard work and contributions to the ACNM”. (Feb. 2014)

Invited Guest Editor, Journal of Nuclear Medicine, Prostate Cancer (2016)

Distinguished Investigator Award, Academy of Radiology Research (2014) -- -- ("The recipients of the award have made significant contributions to the field of imaging research and are in the top 10% of Radiology Department faculty nationwide”)


ACADEMIC APPOINTMENTS 


Research Assistant, University of Wisconsin-Madison, Department of Human Oncology, Madison, WI
(Aug 1983-May 1984)

Project Assistant, University of Wisconsin-Madison, Department of Medical Physics, Madison, WI
(June-Aug 1984)

Teaching Assistant, University of Michigan, Department of Electrical Engineering & Computer Science, Ann Arbor, MI (1985)

Research Assistant, University of Michigan, Medical Computing Laboratory, Department of Electrical Engineering & Computer Science , Ann Arbor, MI
(Aug 1984-Aug 1988), Director: JM Jenkins, PhD)

Research Engineer, Arzco Medical Electronics, Inc, Chicago, IL
(Sept 1986-Aug 1988)

Research Associate, Illinois Institute of Technology, Pritzker Institute of Medical Engineering, Chicago, IL
(Sept 1986-Aug 1988), Director: RC Arzbaecher, PhD

Senior Research Engineer, Arzco Medical Electronics, Inc., Chicago, IL
(Sept 1988-Sept 1989)

Teaching Assistant, University of Chicago, Pritzker School of Medicine, Chicago, IL
(Oct 1990-March 1991)

Senior Research Associate, Illinois Institute of Technology, Pritzker Institute of Medical Engineering, Chicago, IL
(1989-1992), Director: RC Arzbaecher, PhD

Medical Resident I, University of California, San Francisco, School of Medicine, San Francisco, CA
(June 1993-June 1994)
Director: R Watchner, MD, Chairman: F Rector, MD
Moffett-Long Hospital-4 months
San Francisco General Hospital-5 months
San Francisco Fort Miley VA Hospital-3 months

Radiology Resident, Stanford University, School of Medicine, Stanford, CA
(July 1994-June 1996)
Residency Director: RE Mindelzun, MD, Chairman: GM Glazer, MD
Stanford University Hospital-12 months
Lucile Salter Packard Children's Hospital at Stanford-2 months
VA Palo Alto Health Care System-10 months

Instructor, University of California, Berkeley, Department of Continuing Education, Berkeley, CA
(1996-1998)

Nuclear Medicine Resident, Stanford University, School of Medicine, Stanford, CA
(July 1996-June 1998)
Residency Director: IR McDougall, MD, PhD, Chief: HW Strauss, M.D.
Stanford University Hospital-16 months
VA Palo Alto Health Care System-8 months

Nuclear Medicine Chief Resident, Stanford University, School of Medicine, Stanford, CA
(July 1997-June 1998)

Clinical Fellow in Radiology, Harvard Medical School, Joint Program in Nuclear Medicine, Boston, MA
(July 1998-June 1999)
Program Director: SJ Adelstein, M.D., Ph.D., Fellowship Training Director: ST Treves, MD
Official Appointment: Department of Radiology, Brigham &Women's Hospital
Massachusetts General Hospital, PET Imaging Center-7 months (Director :AJ Fischman, MD, PhD)
Children's Hospital-2 months service and 12 months Emergency Call Coverage
Dana-Farber Cancer Institute-3 months service and 12 months Emergency Call Coverage
Brigham & Women's Hospital and West Roxbury VA Hospital-12 months Emergency Call Coverage

Assistant Professor of Radiology (Tenure-Track)
University of Southern California, Keck School of Medicine, Los Angeles, CA
(July 1999-present)
Director of Nuclear Medicine: RW Henderson, M.D., Chairman of Radiology : EG Grant, MD
LAC+USC Medical Center, USC/Norris Comprehensive Cancer Center, USC University Hospital, USC PET Imaging Science Center, Foothill Cardiology/California Heart Medical Group Inc., USC Radiology Associates & Diagnostic Imaging Network (Glendale, CA and Riverside, CA)

Visiting Associate in Bioengineering, California Institute of Technology, Pasadena, CA
(2001-2006)
Host Faculty
: M Gharib, PhD

Assistant Professor of Biomedical Engineering (Joint Appointment with Radiology)
University of Southern California, Los Angeles, CA
(July 2001-present)
Chairman: N Grzywacz, PhD

Faculty Member, Programs in Biomedical and Biological Sciences (PIBBS)
University
of Southern California, Los Angeles, CA
(July 2001-present)

Interim Director, Nuclear Medicine Residency Program
University of Southern California, Los Angeles, CA
(Nov 2003-Jan 2004)

Associate Professor of Radiology (with Tenure)
University of Southern California, Keck School of Medicine, Los Angeles, CA
(July 2005-present)
Chairman
: E Grant, MD

Associate Professor of Biomedical Engineering (Joint Appointment with Radiology)
University of Southern California, Los Angeles, CA
(July 2005-present)
Chairman: M Khoo, PhD

USC Norris Comprehensive Cancer Center Faculty Member

University of Southern California, Los Angeles, CA
(July 2005-present)
Director: S Gruber, MD, PhD, MPH

Vice Chair of Research, Department of Radiology
University of Southern California, Keck School of Medicine, Los Angeles, CA
(Jan 2006-present)

Center for Excellence in Research (CER) Faculty Fellow
University of Southern California, Los Angeles, CA
(2007-2010)

 

USC Wireless Health Technology Faculty

University of Southern California, Ming Hsieh Department of Electrical Engineering, Los Angeles, CA

(2013-present)


PROFESSIONAL EXPERIENCE 


Research Experience (Major Projects) :

University of Wisconsin-Madison, WI (1982-1984)
-Instrumentation for characterization of the thermal properties of ultrasonic tissue-mimicking materials (Mentor : JA Zagzebski)
-Master's Thesis Research (Advisor: WH Dennis, PhD)

University of Michigan, Ann Arbor, MI (1984-1988)
-Doctoral Dissertation Research
(Committee Members: JM Jenkins, PhD, Chairperson, DJ Anderson, PhD, RC Arzbaecher, PhD, M Schwaiger, MD, WJ Williams, PhD)

University of Michigan, Ann Arbor, MI, and Arzco Medical Electronics, Inc., Chicago, IL (Sept 1986-Sept 1989)
-Testing of a real-time ocular counterroll instrument ( Mentor: DJ Anderson)
-Design and development of electrodes and instrumentation for esophageal electrocardiography and cardiac pacing (Mentors : JM Jenkins, RC Arzbaecher)

Illinois Institute of Technology and University of Chicago, Chicago, IL (April 1989-Aug 1992)
-Development of computer algorithms for automatic tachyarrhythmia detection (Mentor: RC Arzbaecher)

Stanford University, Stanford, CA (1996-1998)
-PET applications in clinical cardiology and oncology
-Brain perfusion SPECT imaging of attention deficit disorder
-Sentinel lymph node lymphoscintigraphy in breast cancer

Harvard Medical School, Joint Program in Nuclear Medicine, Boston, MA (1998-2000)
-Activity and size estimation of the striatum dopamine transporter density with SPECT imaging
-Positron emission tomography (PET) applications in clinical oncology

University of Southern California, Los Angeles, CA (July1999-)
-Clinical applications of PET and PET-CT in oncology
-Discrimination of inflammation from cancer with dynamic FDG-PET kinetic analysis (ACS Grant)
-Implication of coronary collateralization on the assessment of myocardial viability (SNM Pilot Grant)
-Oxidative metabolism in cancer: validation study with C-14 acetate autoradiography and MicroPET (RSNA Seed Grant)
-Pre-clinical study of choline in prostate cancer with autoradiography and MicroPET (The Wright Foundation Grant)
-PET study of retinal prosthesis functionality (DOE)

-Multimodality molecular imaging of prostate cancer (R01/R21 NIH-NCI Grants)

 

California Institute of Technology, Pasadena, CA (200-2006)
-Method for monitoring the electrical activity of the developing zebra fish (Danio rerio) heart

Harvard School of Public Health, Boston, MA (2004-2005)
-Decision tree sensitivity and cost-effectiveness analyses of FDG PET in staging of the axilla in T1/T2 N0 breast cancer

Clinical Interests:

-General nuclear medicine

-Nuclear cardiology

-Targeted radionuclide therapy

-PET/CT, PET/MRI, SPECT/CT

 

Current Research Interests:


-Translational research related to molecular imaging with PET in in prostate cancer
-PET and PET-CT in cost-effective clinical decision-making, outcome research, and management of patients with cancer

 

Current Participation in USC Clinical Protocols:

4P-09-5: A Randomized Phase 2 Trial of Radiolabeled (177Lu-J591) in Patients with High-Risk Castrate Biochemically Relapsed Prostate Cancer after Local Therapy

4P-13-7: A Retreatment Safety Study of Radium-223 Dichloride in Subjects with Castration-Resistant Prostate Cancer with Bone Metastases who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 Kbq/Kg Every Four Weeks

4P-13-8: A randomized open-label phase IIa study evaluating quantified bone scan response following treatment with radium-223 dichloride alone or in combination with abiraterone acetate or enzalutamide in subjects with castration-resistant prostate cancer (CRPC) who have bone metastases

 

Teaching Experience:

University of Michigan, Ann Arbor, MI (Jan-April 1985)
-Digital Design Laboratory (Department of Electrical Engineering and Computer Science; 1 semester unit, undergraduate senior level)

University of Chicago, Chicago, IL (Oct 1990-March 1991)
-Patient History Taking (Department of Medicine; first-year medical school level)

University of California, Berkeley, Department of Continuing Education, Berkeley, CA (1996-1998)
-Bioengineering: Introduction to Medical Instrumentation (A new 15-hour course proposed and developed by me and approved by the Department of Electrical Engineering and Computer Science at UC-Berkeley as equivalent to 1 semester unit at the undergraduate senior/graduate level)

University of Southern California, Los Angeles, CA (1999-present)
-Clinical Nuclear Medicine (Department of Radiology; Education of medical students, residents, fellows, and technologists)
-Organizer, Nuclear Medicine Journal Club (2000-2003)
-Organizer, Nuclear Cardiology/Coronary Angiography Case Correlation (2000-2004)
-Organizer, Molecular Imaging Seminar Series (2001-2005)
-Faculty Mentor
1. A. Epstein, USC MSII (PET in the evaluation of breast cancer--published SNM 2003 abstract)
2. A. Xu, P. Tumeh, J. Pollock, USC MS IV's (Serial FDG PET-CT in the evaluation of lymphoma--Published RSNA 2005 abstract )
3. A. Forouhar, Caltech Bioengineering PhD Candidate (Monitoring the electrical activity of the developing zebra fish heart-- published IEEE-EMBS 2004 article)
4. F. Saremi, M.D., Radiology Resident/Fellow (Pharmacologic interventions in nuclear radiology--published Radiographics 2002 article)
5. S. Gamie, M.D., S. Bonyadlou, M.D., Nuclear Medicine Residents (Coincidence imaging of lung and colon cancer--published WSNM and ACNP 2003 abstracts)
6. H. Kherbache, M.D., Nuclear Medicine Resident (FDG PET and prostate cancer-- published Oncology Reports and Clinical Nephrology 2003 article)
7. F. Wang, M.D., Nuclear Medicine Fellow (Coincidence imaging and myocardial viability--published SNM 2002 abstract)
8. H. Wassef, M.D., Radiology Junior Faculty (FDG PET in the evaluation of pancreatic cancer--published RSNA 2002 abstract)
9. L. Ho, M.D., PET Fellow (FDG PET in breast cancer osseous metastases--published SNM 2006 abstract; Clin Nucl Med  case reports)
10. B. Huang, M.D., PET Fellow (FDG PET in acute and chronic leukemia--published SNM 2006 abstract)
11. S. Sadda, M.D., (Project Assistant -- 25% financial support for work on R01 research project)
12. P. Wadhera, USC Graduate Student  (Project Assistant -- 25% financial support for work on R01 prostate cancer research project)
13. A. Gurbuz, USC Undergraduate Student (Translational imaging research on prostate cancer -- published ASCO Prostate Cancer Symposium 2007 and SNM 2008 abstracts)
14. K Rona, USC Undergraduate Student (Translational imaging research on prostate cancer -- published AMI/SMI 2007 abstract)
15. T. Wells, USC MSII (Student Assistant -- R01 prostate cancer research project)
16. L. Hovanessian-Larson, M.D., Radiology Junior Faculty (MRI in breast cancer -- Komen Foundation grant award)
17. A. Nacca, Ph.D., Radiology Junior Faculty (PET imaging of hypoxia in prostate cancer -- American Cancer Society grant award)

18. L. Carlton, USC MPH Student (R01 prostate cancer research project)

19. H. Modaressifar, PET-CT Fellow (Breast and head & neck cancer—published SNM 2008 and RSNA 2008 abstracts)

20. V. Quan, M.D., PET-CT Fellow (Bladder cancer—published IJCO 2008 article)

21. S. Shams, M.D., Visiting Physician (Breast and head and neck cancer—published SNM 2008 and RSNA 2008 abstracts)

22. J. Montgomery, MSTP Student (PET in cervical cancer)

23. L. Pourzand, M.D., USC Internal Medicine Resident (colon cancer and liver metastasis prediction)

24. J. Xie (FDG PET in functionality of retinal prosthesis)

25. M. Meka, M.D., PET-CT Fellow (colon cancer and liver metastasis prediction)

25. S. Schroff, USC MSIV (R01 prostate cancer research project)

27. M. Hendricks, USC MSIV (R01 prostate cancer research project)

28. B. Desai, USC MS Student (R01 prostate cancer research project; completed MS Thesis, August 2010; Recipient of 1st Prize in the USC GSC-STEM  Poster Symposium 2012)

29. L. Al-Rabadi, Visiting MSIV, Royal College of Surgeons, Dublin, Ireland (R01 prostate cancer research project)

30. A. Kouhi, USC Pharmacy Graduate student (R21 preclinical project on FMAU in prostate cancer – co-author on an article in Molecular Imaging 2012)

30. M. Nayyar, USC MSI (R01 prostate cancer research project)

31. Mike Kwon, USC MSIII – Dean’s Student Scholar (R01 prostate cancer research project)

32. Chung Yao Yu, USC MSIII (meta-analysis of PET in prostate cancer)

33. James Yoon, USC MSII (PSA sensitivity of 18F-NaF PET/CT in biochemical recurrence of prostate cancer – In collaboration with Leslie Ballas, MD, USC Dept. of Radiation Oncology)

 

-Doctoral Dissertation Committee Member
1. Javier A. Jo (Ph.D. Candidate, Department of Biomedical Engineering, Cardiovascular variability in obstructive sleep apnea; 2001)

2. Anna Blasi (Ph.D. Candidate, Department of Biomedical Engineering, Time-varying analysis of autonomic cardiovascular control during arousal from sleep; 2001)

3. Siti Mohtdjani (Ph.D. Candidate, Department of Pharmaceutical Sciences, 2008-)

4. John Xie (Ph.D. Candidate, Department of Biomedical Engineering, PET study of retinal prosthesis functionality; 2009)

5. Chiun-Wei Huang (Ph.D. Candidate, Department of Biomedical Engineering, A Novel Design of Integrin a2b1 Targeting Peptide Probes for Molecular Imaging in Prostate Cancer; 2010)

6. Joyita Dutta (Ph.D. Candidate, Department of Electrical Engineering, Computational methods for fluorescence molecular tomography; 2011)

California Institute of Technology, Pasadena, CA (December 2001)
-Cardiac Pathophysiology: Bioengineering Applications (Bioengineering Program; BE200 undergraduate senior/graduate level)

Industrial Experience:

Arzco Medical Electronics, Inc. , Chicago, IL (Sept 1986-Sept 1989)
-Research and Development (Transesophageal Cardiac Stimulator and Biopotential Amplifier, Stimulus Artifact Suppressor for esophageal cardiac pacing, Affixable Esophageal Sheet for cardiac pacing during transesophageal echocardiography, Variable stiffness and Expandable esophageal catheters); Collaboration with clinicians to procure and evaluate new ideas; Laboratory demonstration of company products at major meetings; Preparation of publication literature pertaining to products; Technical training support for sales and manufacturing; Compliance with device regulatory affairs; Management of various product-related clinical studies

Selected Graduate and Continuing Education Courses:

University of Wisconsin-Madison, WI (1982-1984)
Bioengineering (Medical Instrumentation, Computers in Medicine, Medicine and Clinical Engineering, Biomechanics, Diagnostic Ultrasound Physics)
Computers (Machine Language Programming, Logic Design, Microprocessor Laboratory)

University of Michigan, Ann Arbor, MI (1984-1988)
Bioengineering (Electrical Biophysics, Biomedical Instrumentation and Design, Radiology and Nuclear Medicine, Neurophysiological Systems)
Information Engineering (Signal Processing and Analysis, Digital Signal Processing, Digital Design Laboratory, Biosignal Processing, Advanced Signal Processing, Pattern Recognition, Artificial Intelligence)
Mathematics (Probability Theory and Random Processes, Complex Variables)

Stanford University, Stanford, CA
-Basic Radiation Protection (Sept 1996)
-Small Animal Imaging Workshop (Nov 2006)

University of California, Berkeley, Extension, Berkeley, CA
-Wilderness Emergency Medicine (April 1997)
-Current Issues and Careers in Public Health (Oct 1996)

Armed Forces Institute of Pathology (AFIP), Washington, DC
-Radiologic-Pathology Correlation (6-week curriculum: April-May 1998)

Massachusetts General Hospital, Clinical Research Program, Boston, MA
-Scientific Writing (Oct 1998)

Harvard University, Extension School, Cambridge, MA
-Genetic Engineering (Sept 1998-Jan 1999)

Harvard Medical School, Boston, MA
-Clinical Nuclear Medicine (April 1999)
-MGH/BWH Radiology Review (April 1999)

National Institutes of Health, Bethesda, MD
-Biomedical Imaging Symposium: Visualizing the Future of Biology and Medicine (June 1999)

-Imaging and Oncology: How to Build a Successful Partnership (October 2004)

Radiological Society of North America, Chicago, IL
-Revitalizing the Radiology Research Enterprise (RRRE) Workshop (October 2005)

 

Cedars-Sinai Medical Center, Los Angeles, CA

-Nuclear Cardiology and Cardiac CT (January 2008)

 

Harvard University, Cambridge, MA
Summer Fellowship Program in Clinical Effectiveness (July 1-August 15, 2003)
A Joint Program of the Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, and Harvard School of Public Health, "designed for the clinician seeking the quantitative and analytic skills needed for clinical research and health care administration"
Curriculum Courses: Introduction to Biostatistics, Advanced Statistics for Medical Research, Clinical Epidemiology, Research Synthesis and Meta-Analysis in Public Health and Medicine, Decision Analysis in Clinical Research
Master of Public Health (MPH) Degree Program (Summer-Only; Clinical Effectiveness Concentration)
(Part I (See above): July 1-August 15, 2003; Part II: July 1- August 15, 2004; Part III : July 5-29, 2005)
Curriculum Courses: Ethical Basis of the Practice of Public Health, Society and Health, Principles of Environmental Health, Survival Methods in Clinical Research, Principles of Clinical Trials, Linear and Longitudinal Regression, Analytical Clinical Epidemiology, Practicum Project (Topic: Decision Tree Sensitivity Analysis of FDG PET in Axillary Staging of Breast Cancer)

University of Cambridge, Selwyn College, Cambridge, UK
International Summer School, Term II (August 5-18, 2007)
Courses (by Prof. Piers Bursill-Hall - Lecturer, Department of Pure Mathematics):
I. Renaissance arts and science: Brunelleschi to Galileo
II. The origins of modern science: the scientific revolution
III. The other middle ages: the Islamic world and the Latin debt to Islam
Evening Lectures
: Hampton Court : 'The greatest English palace' by Dr. Jonathan Foyle, Britain 's changing landscape, AD300-1900 by Dr. Nicholas James, Shakespeare and the Middle Ages by Prof. Helen Cooper, Making the Earth move: 1200-1600 by Prof. Piers Bursill-Hall, An introduction to Love’s Labour’s Lost by Dr. Catherine Alexander, Shakespeare from manuscript to print by Dr. Alexander Lindsay, The fate of Faerie by Dr. Stewart Eames, One, two, three: Twelfth Night deconstructed and performed by Prof. Eunice Rober

University of Oxford, Christ Church College, Oxford, UK

The Oxford Experience 2008 (Colleges of Oxford: Exploring the historic colleges and buildings of the university and city in the context of the origins of the town and growth of the university including a look at the changing architectural styles of the buildings, the college gardens and the surrounding countryside – Excursions to St. Catherine’s & Wolfson colleges and South Park, Wolvercote & Boars Hill, Oxfordshire – by John Munby)


University of Southern California, Los Angeles, CA
-Business Fundamentals for Healthcare Practitioners (Jan-May 2000)
-Methods in Clinical Investigation (Oct 2000)
-Responsibilities and Requirements for the Protection of Human Subjects in Research (Feb-March 2001)
-Humane Care and Use of Laboratory Animals (April 2002)
-Laboratory Safety (May 2002)
-Emergency Preparedness (Oct 2004)
Executive Master of Business Administration (MBA) Degree Program, Marshall School of Business (August 2005-May 2007)
Theme I: Top Management Perspective (One-week Residential in Ojai, CA), Theme II: Evaluating Market Performance; Theme III : The General Manager as Integrator; Theme IV: Operations and Information Systems Management; Theme V: Consulting Project; Theme VI: Environmental Analysis: Establishing Competitive Advantage; Theme VII: Dynamics of Global Competition (One-week Residential in Shanghai, China); Theme VIII : Strategic Planning for Growth and Profitability; Theme IX: Managing Strategic Changes and Implementation; Theme X: Executive of the Future (Three-day Residential in Rancho Bernardo, CA)

University of Pennsylvania, Wharton School of Business, Philadelphia, PA

-The Leadership Journey: Creating and Developing your Leadership (September 27-October 2, 2009)


MAJOR PROFESSIONAL ACTIVITIES 


Professional Organizations Activity:

 

Academy of Radiology Research (ARR)

-Board of Directors (appointed by the Society of Nuclear Medicine and Molecular Imaging)(2015-)

 

Computers in Cardiology

-Local Organizing Committee Member, 17th International Conference, Chicago, IL (1990)

 

California Medical Association (CMA)

-Nuclear Medicine Scientific Committee Member, Council on Scientific Affairs (2002-2005)

 

IEEE Engineering in Medicine and Biology (IEEE-EMBS)

-Session Chairman, "Biomedical Research Instrumentation", 11th Annual International Conference, Seattle, WA (1989)

-Track Co-Chair, "Imaging in Drug Discovery, Development and Therapy", 18th Annual International Conference, New York, NY (2006)

 

American College of Nuclear Medicine (ACNM) [ACNM and ACNP merged into ACNM in 2009]

-Board of Representatives Member (2003-2006)

-Scientific Program Chair and Course Moderator (2008)

-Director-at Large (20010-13)

-Membership Committee Member (2010-2011)

-Publications/Editorial Board Committee Member (2010-2011)

-Chair, Strategy Summit (2012)

-Representative, ACR 2012 Intersociety Summer Conference (Radiology Online: Information, Education, and Networking), Telluride, CO (August 2012)

-Representative, ACR 2013 Intersociety Summer Conference (Radiology Journals in Transition), Big Sky, MT (August 2013)

-Chair, Nominations Committee (2014-2015)

-Chair, Awards Committee (2014-2015)

-President-Elect (2012-2013)

-President (2013-2014)

-Immediate Past President (2014-2015)

 

American College of Nuclear Physicians (ACNP) [ACNM and ACNP merged into ACNM in 2009]

-Board of Regents Member (2004-2006)

-Scientific Program Organizing Committee Member (2004)

-Scientific Program Organizing Committee Co-Chair (2005)

-Publications Committee Member (2007)

 

Society of Nuclear Medicine and Molecular Imaging (SNMMI)
-Task Force member, TeleNuclear Medicine (2001, 2013)

-Task Force member, SPECT-CT Guidelines (2006)

-Task Force member, Radiotherapy with Unsealed Sources (2009, 2011)

-Task Force member, PET COE: PET/MRI (2012-2013)

-Task Force Chair, PET COE: Radiotracer Encyclopedia, (2012-2014)

-Continuing Medical Education Faculty Member (2002, 2003)

-ACNP/SNM Joint Government Relations Committee (2003-2005)

-PET Center of Excellence Board of Directors (2008-2011)

-PET COE Newsletter Editorial Board Member (2009-present)

-Scientific Program Sub-Chair, (Solid Tumors: Oncology-Clinical Diagnosis Track)(2009-2010)

-Scientific Program Vice-Chair, (Basic, Translational and Molecular Imaging - Oncology)(2011-13)

-Pacific Southwest Chapter President (2009-2010)

-House of Delegates member, Pacific Southwest Chapter Delegate (2009-2013)

-Contributor to SNM response letter to National Comprehensive Cancer Network (NCCN) – (Utility of PET-CT in Neuroendocrine tumors)

-Database Subcommittee, Clinical Trials Network (2009-10)

-Steering Committee member, Western Regional SNM meeting, (2009-12)

-SNM Continuing Education Organizer, Salt Lake City, UT (Imaging of Prostate Cancer)(2010)

-Scientific Chairman, Western Regional SNM meeting, Anaheim, CA (2010)

-Liaison to the European Association of Nuclear Medicine on “Prostate cancer imaging”, Vienna, Austria (2010)

-Correlative Imaging Council Board of Directors (2010-2014)

-Director-at-Large, SNM Board of Directors (2010-13)

-Co-Chair (with Michael Graham, PhD, MD), Academic Physicians Group, SNM 2020 Task Force (2011)

-Member, SNM Name Change Task Force (2011)

-Participant, SNM Capitol Day (Offices of Sen. Feinstein, Sen. Boxer, Sen. Rubio, Rep. Schiff, Rep. Eshoo)(May 2, 2011)

-Vice President, PET Center of Excellence (2011-13)

-President, PET Center of Excellence (2013-15)

-Committee on Publications (2003-2014); Chair (2012-14)

-Committee on Education (2012-present)

-Committee on Ethics (2013-present)

-Committee on Councils and Centers (2012-present)

-Committee on Finance (2013-present)

-Committee on Outreach (2013-prrsent)

-Committee on Public Relations (2013-present)

-Co-Chair (with Andrei Iagaru, MD), Targeted Radionuclide Therapy Working Group, Outreach Committee (2012-present)

-Co-Chair (with Rathan Subramaniam, SNMMI-ACR Joint Task Force on PET/MRI Credentialing (2013-present)

-Representative, ACR 2014 Intersociety Summer Conference (Reengineering Radiology Enterprise), Santa Fe, NM (August 2014)

-Member, International Membership Group, Membership Task Force (2014-)

-Vice President-Elect (2013-2014)

-President-Elect (2014-2015)

-President (2015-2016)

-Immediate Past President (2016-2017)

 

Los Angeles Radiological Society (LARS)

-Conference Organizing Committee Member (2003-09)

-Nuclear Medicine Conference Program Chair (2008)

-Nuclear Medicine Section President (2007-2010)

-Conjoint LARS-SNM PSW Chapter Nuclear Medicine Conference Program Chair (2010)

 

Radiological Society of North America (RSNA)

-“Image Wisely” PET/CT Committee Leader (2012)

Conference Invited Faculty Member and Moderator Activity:

American College of Osteopathic Internists (ACOI)

-Cost-Effectiveness and Matchless Impact of PET-CT in Cancer Management. Orlando, FL (October 2012)

-Translational to Clinical Molecular Imaging of Prostate Cancer: PET/CT and PET/MRI. Indian Wells, CA (October 2013)

 

Academy of Persian Physicians (APP)

-Annual Meeting, Indian Wells, CA (Presentation: Translational and clinical molecular imaging in the 21st century; Moderator: Morning Scientific Session)(2007)
-Annual Meeting, Santa Barbara, CA (Presentation: Emerging diagnostic role of PET in prostate cancer)(2008) [NIH-NCI R01-CA111613 Support]

 

American College of Nuclear Medicine (ACNM)

-27th Annual Meeting, New Orleans, LA (Presentations: I. Pitfalls in Oncologic PET; II. PET Applications in Pediatrics)(2000)

-28th Annual Meeting, Tampa, FL (Presentation: Cardiac Positron Emission Tomography)(2001)

-29th Annual Meeting, Scottsdale, AZ (Presentation: Pediatric PET)(2002)

-30th Annual Meeting, San Antonio, TX (Presentation: PET Imaging of Infection and Inflammation)(2003)

-33rd Annual Meeting, San Antonio, TX (Presentation: PET and PET-CT in Pediatric Oncology)(2006)

-34th Annual Meeting, Orlando, FL (Presentation: PET and PET-CT of prostate cancer; Moderator: Emerging clinical applications of PET)(2008) [NIH-NCI R01-CA111613 Support]

-Joint ACNM-SNM 2010 Mid Winter Symposium, Albuquerque, NM (Presentation: Emerging Role of PET in Prostate Cancer)(2010) [NIH-NCI R01-CA111613 Support]

-Joint ACNM-SNM 2011 Mid Winter Symposium, Palm Springs, CA (Presentation: Healthcare Reform: Challenges and Opportunities for Imaging)(2011)

 

American College of Nuclear Physicians (ACNP) [ACNP and ACNM merged in 2010 to ACNM]

-Annual Meeting, Marco Island, FL (Presentation: PET Evaluation of Inflammatory Diseases)(2004)

-Annual Meeting, San Diego, CA (Moderator: Plenary Session and Scientific Abstracts)(2005)
-Annual Meeting, Newport Beach, CA (Presentation: Leadership and Management)(2008)
-Joint ACNP, ACNM, SNM 2009 Mid Winter Symposium, Clearwater, FL (Presentation: Leadership: An important component of life)(2009)

 

American Urological Association (AUA)

- Joint AUA-NCI Prostate and Genitourinary Cancer Specialized Programs of Research Excellence (Presentation: Targeted Radionuclide Therapy)(May 2014)

 

City of Hope Cancer Center

-GU Oncology Conference, Coronado, CA (Presentation: PET-CT of urologic malignancy)(2009) [NIH-NCI R01-CA111613 Support]

 

European Association of Nuclear Medicine (EANM) – Vienna, Austria (2010); Gothenburg, Sweden (2014)

-Symposium 13: Prostate Cancer Multicenter Trial & Round Table, (Symposium Co-Chair; Presentation: Role of various PET tracers in prostate cancer; Session Chair: Prostate Cancer & Urogenital); Vienna, Austria (October 2010)

-EANM/SNMMI Joint Symposium: Translation molecular imaging of prostate cancer with PET; Gothenburg, Sweden (October 2014)

 

International Atomic Energy Agency (IAEA)-sponsored First Symposium on Radiopharmacy in Africa, Addis Ababa, Ethiopia

-“Impact of PET/CT in clinical management of cancer”, “Translational and clinical PET in prostate cancer”, “Targeted alpha therapy of castrate-resistant metastatic prostate cancer” (November 2013)

 

International 1st “State-of-the-Art Conference on Prostate and Kidney Cancer, Amsterdam, The Netherlands

-“Molecular Imaging in Prostate Cancer: What will Future Bring Us?”, and “Novel Techniques for detection of Prostate Metastases (September 2013)

 

International 1st Symposium of Translational Theranostics, Shenzhen, China

-“Speaker and Session Chair: Clinical and Translational Molecular Imaging and Therapy of Prostate Cancer” (May 2014)

 

Los Angeles Radiological Society (LARS)

-54th Annual Midwinter Meeting, Los Angeles, CA (Presentations: I. The Role of PET in Lung Neoplasms; II. Head and Neck Malignancies: Evaluation with PET)(2002)

-55th Annual Midwinter Meeting, Los Angeles, CA (Moderator: PET/Nuclear Medicine Track)(2003)

-56th Annual Midwinter Meeting, Los Angeles, CA (Moderator: Nuclear Medicine, PET, SPECT Track)(2004)

-60th Annual Midwinter Meeting, Los Angeles, CA (Presentation: PET and PET-CT in prostate cancer)(April  2008) [NIH-NCI R01-CA111613 Support]

-61st Annual Midwinter Meeting, Los Angeles, CA (Presentation: PET-CT evaluation of GU malignancies; Moderator: Oncology and Molecular Imaging)(2009)

-Conjoint LARS-SNM PSW Chapter Meeting, Pasadena, CA (Conference Scientific Chairman; Presentation: Molecular biology correlates of FDG uptake in tumors)(2010)

-Conjoint LARS-SNM PSW Chapter Meeting, Pasadena, CA (Presentation: Clinical Impact of PET/CT)(2011)

-Conjoint LARS-SNMMI PSW Chapter Meeting, Pasadena, CA (Presentation: Radium-223 dichloride in treatment of prostate cancer bone metastases)(2015)

 

Radiological Society of North America (RSNA)

-97th Annual Meeting, Chicago IL (Refresher Course: Choline imaging in oncology)(2011) [NIH-NCI R01-CA11161 and R21-CA142426 Support]

-98th Annual Meeting, Chicago, IL (Refresher Course: Imaging of prostate cancer)(2012) [NIH-NCI R01-CA11161 and R21-CA142426 Support]

-99th Annual Meeting, Chicago, IL (Refresher Course: Prostate cancer choline PET imaging and other PET tracers)(2013) [NIH-NCI R01-CA11161 and R21-CA142426 Support]

-100th Annual Meeting, Chicago, IL (Refresher Course and Co-Moderator: Prostate Cancer Choline PET Imaging and Other PET Tracers)(2014)

 

Society of Nuclear Medicine and Molecular Imaging (SNMMI) [SNM changed its name to the Society of Nuclear Medicine and Molecular Imaging, SNMMI, in June 2012]

-Joint AMI-SNM Positron Imaging Symposium, VA Palo Alto Health Care System, Palo Alto, CA (Presentation: PET-CT for Staging Cancers of the Abdomen and Pelvis)(2005)

-54th Annual Meeting, Washington, DC (PET Center of Excellence Presentation: Brown fat metabolism and its modulatory factors; Moderator: Lung: lymph node and pleural evaluation, radiotherapy)(2007)
-55th Annual Meeting, Washington, DC (PET Center of Excellence Presentation: Optimizing PET-CT: Reducing physiologic FDG uptake)(2008)

-56th Annual Meeting, Toronto, Ontario, Canada, (PET Center of Excellence Presentation: How and why to reduce bladder activity?)(2009)

-34th Annual Meeting Western Regional SNM, Monterey, CA (Presentation: PET-CT in urologic malignancy; Moderator: Taplin Memorial Lecture, Pediatric and GU Oncology Sessions)(2009) [NIH-NCI R01-CA111613 Support]

-57th Annual Meeting, Salt Lake City, UT, (PET Center of Excellence Continuing Education Organize: PET/CT in Management of Urologic Malignancies; Presentations: I. Role of Imaging and FDG PET in Prostate Cancer; II. Nuclear Oncology Council Sponsorship: Current status and future of PET imaging of prostate cancer)(2010) [NIH-NCI R01-CA11161 Support]

-35th Annual Meeting Western Regional SNM, Garden Grove, CA (Conference Scientific Chairman; Presentations: I. Challenges in Imaging of Prostate Cancer; II. PET in Rheumatology)(2010) [NIH-NCI R01-CA111613 Support]

-2011 Mid Winter Multimodality Molecular Imaging of Prostate Cancer Symposium, Palm Springs, CA (Presentation: PET in Prostate Cancer)(2011) ) [NIH-NCI R01-CA11161and R21-CA142426 Support] [Webcast]

-58th Annual Meeting, San Antonio, TX (PET Center of Excellence Continuing Education Organize: Non-FDG tracers in PET, Presentation: PET imaging of lipogenesis (acetate and choline); Correlative Imaging Council Continuing Education Organizer: Multi-modality imaging of prostate cancer; Presentation: PET in prostate cancer; Co-Moderator: Prostate Cancer Imaging - EANM)(2011) [NIH-NCI R01-CA11161 Support]

-Pacific Southwest Chapter Technologist Section, “Viva Las Vegas” Annual meeting, Las Vegas, NV (Presentations: I. PET in prostate cancer; II. Healthcare reform)(2011) [NIH-NCI R01-CA11161 Support]

-33rd Missouri Valley Chapter, Lake Ozarks, MO (Presentation: Emerging role of PET in prostate cancer)(2011) [NIH-NCI R01-CA11161 Support]

-36th Annual Meeting Western Regional SNM, Seattle, CA (Presentation: Multimodality and hybrid imaging of prostate cancer)(2011) [NIH-NCI R01-CA11161and R21-CA142426 Support]

-59th Annual Meeting, Miami Beach, FL (Invited Speaker and Moderator: Integrated Session: Prostate Cancer; Organizer and Moderator: PET Update in GI Oncology, Presentation: PET/CT in HCC and GEP Neuroendocrine Tumors; Moderator: PET Boot Camp: Mind, Body, and Spirit) [NIH-NCI R01-CA11161and R21-CA142426 Support]

-37th Annual Meeting Western Regional SNM, Monterey, CA (Presentation: Prostate cancer imaging: challenges and opportunities; Organizer and Moderator of several sessions including introduction of Sanjiv S. Gambhir, MD, PhD, for the Distinguished Scientist Award)(2012) [NIH-NCI R01-CA11161and R21-CA142426 Support]

-2013 Mid Winter ACNM-SNMMI meeting, New Orleans, LA (Joint PET Center of Excellence and Center for Molecular Imaging Innovation and Translation Categorical Co Organize: Different Spin on Nuclear Imaging: the Role of PET-MRI in Molecular Imaging)

-1st NCI/SNMMI Workshop on Targeted Radionuclide Therapy, Bethesda, MD (Presentation: Highlights and Future Direction)(2013)

-59th Annual Meeting, Vancouver, BC (Joint PET Center of Excellence and Correlative Imaging Council Categorical Co Organizer and Speaker: A Journey from PET/CT to PET/MRI: The need for PET/MRI; Organizer and Moderator: Lymphoma Integrated Session; Moderator: Sodium Fluoride Bone Scanning)(2013)

-Pacific Southwest Chapter Technologist Section, “Viva Las Vegas” Annual meeting, Las Vegas, NV (Presentation: Alpha emitters: a new frontier in therapeutics)(2013)

-38th Annual Meeting Western Regional SNM, Pasadena, CA (Moderator: multiple sessions; Presentations: I. Choline PET imaging in cancer; II: Alpha Particle Therapeutics: The Case for Ra223 Dichloride)(2013)

-60th Annual Meeting, St. Louis, MO (Organizer, Moderator, and Speaker: PET and Multiparametric MRI of Prostate Cancer; Presentations: I. Translational and Clinical PET of Prostate Cancer; II: Imaging Lipogenesis in Cancer)(2014)

-2nd NCI/SNMMI Workshop on Targeted Radionuclide Therapy, Bethesda, MD (Presentation: Highlights)(2014)

-39th Annual Meeting Western Regional SNM, Seattle, WA (Moderator: Radiotherapy; Presentation: Alpha Particles in Metastatic Prostate Cancer)(2014)

-2015 Mid Winter meeting, San Antonio, TX (Organizer, Moderator, and Speaker: CTN-PET CoE Joint Session – Coverage with Evidence Development and Life After NOPR: Best Clinical Practices for PET/CT: NOPR and CED Guidelines – Oncology)(2015)

-Northern California Chapter, Pleasanton, CA (Speaker: Positron Emission Tomography of Prostate Cancer)(2015)

-Pacific Northwest Chapter, Portland, OR (Speaker: Alpha particle therapy of prostate cancer)(2015)

-61st Annual Meeting, Baltimore, MD (Organizer, Moderator, and Speaker: Outcome prediction in cancer with PET: Prognostic utility of PET in Prostate Cancer; Organizer, Moderator, and Speaker: CTN-Outreach Cmte Joint Session: Advances in Prostate Cancer: Imaging, Diagnosis, and Management -- Imaging Metabolic Pathways with FDG and C-11 Acetate in Prostate Cancer)(2015)

 

World Federation of Nuclear Medicine and Biology (WFNMB)

-10th Congress, (Presentations: I. PET/CT in Oncology: Impact on Patient Care; II: Choline Imaging: Potential Clinical Applications; Session Chair: New Horizons for Molecular Imaging and Potential Clinical Applications), Cape Town, South Africa (2010) [NIH-NCI R21-CA142426 Support]

-11th Congress, (Moderator and Presentation : Imaging of prostate cancer in the 21st century: role of PET/CT), Cancun, Mexico (2014)

Invited Professional Visits and Seminar Presentations:

Armenian American Medical Society of California (AAMSC), Glendale, CA
-Topic: PET-CT clinical applications (February 2006)

California Institute of Technology, Pasadena, CA
-Department of Electrical Engineering (Esophageal Electrocardiography and Cardiac Pacing)(January 2000)
-Department of Electrical Engineering (PET)(April 2000)
-Bioengineering Seminar Series (Molecular Imaging of Cancer with PET)(January 2006)

Comprehensive Blood & Cancer Center, Bakersfield, CA
-Topic: Using PET as a tool for diagnosis, staging and restaging of cancers (February 2005)

Georgetown University, Washington, DC

-Department of Radiology Grand Rounds (Molecular Imaging of Prostate Cancer with PET) (September 2014)

Hi-Desert PET Imaging Center, Victorville, CA
-Topic: PET-CT - Changing the way you practice medicine (October 2006)

Martin Luther King/Drew Medical Center, Los Angeles, CA
-Department of Emergency Medicine (Emergency Nuclear Radiology)(April 2000, February 2002)

Medical Education Speakers Network, Santa Ana, CA
-Community Memorial Hospital, Ventura, CA (Cardiac PET)(March 2002)
-South Coast Medical Center, Laguna Beach, CA (PET in Oncology)(April 2003)
-West Anaheim Medical Center, Anaheim, CA (PET)(May 2003)
-Northridge Hospital Medical Center, Van Nuys, CA (Cardiac PET)(April 2004)
-St. Vincent Hospital Medical Center, Los Angeles, CA (PET)(May 2004)
-Citrus Valley Medical Center, Covina, CA (PET in Oncology)(November 2004)

NASA Ames Research Center, Moffett Field, CA
-Advanced Technologies for Gravitational Biology Symposium and Workshop, Life Sciences Division, (NASA Document SLO: 240A-3)(January14-17, 1997)

NASA Jet Propulsion Laboratory, Pasadena, CA
-Center for Space Microelectronics Technology ("Medical Imaging in Microgravity")(February 2001)

Providence Holy Cross Medical Center, Mission Hills, CA

-Topic: PET-CT in Management of Cancer (December 2009)


Prostate Cancer Research Institute, Los Angeles, CA
-Imaging for Recurrent and Advanced Prostate Cancer (California State University-Los Angeles, September 2006)

-Window to Future: PET in Prostate Cancer (Los Angeles, March 2011)

 

Radiological Society of North America, Chicago, IL
-Academy of Molecular Imaging "Read with the Experts" (Clinical PET-CT)(November 2004)

Southland Pre-Health Conference, Los Angeles, CA
"Discover your Place in Medicine" (Workshops designed to guide students through potential careers in healthcare hosted by the USC and UCLA chapters of Alpha Epsilon Delta in association with the USC Pre-Pharmacy Society)(February 2007)

 

University of Arizona, Tucson, AZ

-Frontiers in Medical Research Seminars (Clinical and Translational Molecular imaging of Prostate Cancer with PET)(September 2011) [Webcast]

 

University of California, Irvine, CA
-Department of Radiological Sciences (Clinical PET)(February 2003, October 2003)

University of California, Los Angeles, CA
-Crump Institute for Molecular Imaging (January 2001)

University of North Carolina, Chapel Hill, NC

-Department of Urology 8th Annual Landes Symposium: Advances in Urology (Emerging Role of PET in Prostate Cancer)(June 2010)

-Department of Radiology Resident Lecture (PET in Pediatrics)(June 2010)

 

University of Southern California, Los Angeles, CA
-Grand Rounds, Division of Cardiology, Department of Medicine (Cardiac PET)(January 2000)
-Department of Biomedical Engineering (PET)(April 2000)
-Section of Neuroradiology, Department of Radiology (NeuroPET)(June 2000)
-Grand Rounds, Division of Colorectal Surgery (PET and Colorectal Cancer)(August 2000)
-Department of Biomedical Engineering (Esophageal Electrocardiography and Cardiac Pacing)(September 2000)
-Grand Rounds, Department of Radiology (PET; Bridging mouse and man with molecular imaging)(April 2001; December 2008)
-Grand Rounds, Division of Rheumatology, Department of Medicine (PET Applications in Rheumatology)(June 2002)
-Department of Biomedical Engineering (Molecular Imaging of Cancer with PET)(October 2005)
-Biomedical Imaging Sciences Initiative (BISI) - Charting USC future small animal imaging and molecular/cellular imaging (Focus on cancer)(April 2006)
-Grand Rounds, Norris Comprehensive Cancer Center (Molecular Imaging of Cancer with PET and PET-CT)(May 2006)
-Division of Oncology  (Imaging of Advanced Prostate Cancer)(August 2006)

-Norris Cancer Center Molecular Imaging Seminar (Bridging mouse and man with molecular imaging)(February 2009)

-Norris Cancer Center Clinical Protocol Review (FDG PET in Prostate cancer)(June 2009)

-USC UH Lunch Seminar Series (Role of PET in the Management of Cancer Patient)(August 2010)

-Norris Cancer Center, Division of Hematology-Oncology (Molecular Imaging and PET in Lymphoma)(September 2010)

-Norris Cancer Center, Division of Surgical Oncology-Breast Cancer (PET with 18F-NaF)(February 2011)

-Norris Cancer Center, Department of Urology (PET with 18F-NaF)(February 2011)

-Grand Rounds, Department of Radiology (Healthcare reform and medical imaging)(March 2011)

-USC KSOM Research Seminar Series (Translational and Clinical Molecular Imaging of Prostate Cancer)(April 2011)

-Norris Cancer Center, Department of Oncology (PET with 18F-NaF)(May 2011)

-Norris Cancer Center, Division of Lung Cancer (PET with 18F-NaF)(May 2011)

-Department of Biomedical Engineering (Invited lecturer: BME 525 Medical Imaging: US, CT, SPECT/PET)(March 2013)

-Grand Rounds, Department of Radiology (Molecular Imaging of prostate cancer with PET)(March 2013)

-Molecular Imaging Workshop (Translational and Clinical PET in Prostate Cancer)(November 2013)

-Norris Cancer Center Retreat: Discovery, Development, and Delivery: Technological Advances in Cancer Research (March 2014)


USC Community Hospital Network, Los Angeles, CA
"Molecular Imaging - PET and PET-CT"
-Verdugo Hills Hospital, Glendale, CA (Sept 2001, Jun 2002, Jun 2004, Oct 2004, Apr 2005, Apr 2006, Mar 2007, Oct 2007, May 2008, March 2009)
-Midway Hospital Medical Center, Los Angeles, CA (Nov 2001, Mar 2004, Jun 2004, Apr 2006, Mar 2007)
-Suburban Medical Center, Paramount, CA (Jan 2002, Mar 2004, Apr 2006, Apr 2007, Oct 2007, May 2008, Jan 2009)
-Century City Hospital, Los Angeles, CA (Mar 2002)
-Valley Presbyterian Hospital, Van Nuys, CA (Oct 2002)

 

University of Washington, Seattle, WA

“Multimodality Molecular Imaging of Prostate Cancer” and “Choline imaging in oncology” (February 2012)

Virginia Commonwealth University, Richmond, VA
"Evolving Approaches to Diagnostic Imaging" (CME Symposium held in San Juan, Puerto Rico)(December 2006)

SNMMI Leadership Presentations

 

-38th Western Regional Meeting, Pasadena, CA (October 2013)

-Leadership Academy, Mid Winter Meeting, Palm Springs, CA (February 2014)

-Pacific Northwest Chapter Meeting, Portland, OR (March 2014)

-Southeastern Chapter Meeting, Lake Buena Vista, FL (October 2014)

-39th Western Regional Meeting, Seattle, WA (October 2014)

-Northern California Chapter, Pleasanton, CA (February 2015)

-Pacific Southwest Chapter, Pasadena, CA (February 2015)

-Pacific Northwest Chapter, Portland, OR (March 2015)

 

Journal Editorial Board Member Activity:

-American Journal of Nuclear Medicine and Molecular Imaging (2013-present)

-American Journal of Roentgenology (AJR) – Assistant Editor, Molecular Imaging/Nuclear Medicine Section (2008-present)

-Clinical Nuclear Medicine (2007-present) – Deputy Editor (2010-present)

-European Journal of Nuclear Medicine and Molecular Imaging Research (2011-present)

-European Journal of Nuclear Medicine and Molecular Imaging (2015-present)

-Journal of Nuclear Medicine (2006- present)
-Molecular Imaging and Biology (2004- present)

-Radiology – Associate Editor, Nuclear Medicine Section (2010-present)

-Theranostics (2011-present)

 

Peer Review Activity:

National Institutes of Health (NIH)
-Small Business Innovation Research (SBIR) Program Study Section, Bethesda, MD (1989)

-Subcommittee H – Cancer and Leukemia Group B (CALGB) Study Section, Bethesda, MD (SRO: Timothy C. Meeker, MD, PhD)(10/08)

-NCI-ARRA Grand Opportunity (GO) Study Section, Bethesda, MD (SRO: Jeannette Korczak, PhD)(8/09)

-Special Emphasis Panel (SEP), NCI Loan Repayment Program (LRP) Study Section, Bethesda, MD (SRO: Jan M. Woynarowski, PhD)

[LRP: 5/10, 5/11, 5/12, 5/13]

-In Vivo Cellular and Molecular Imaging Centers (ICMICs) Study Section, Bethesda, MD (SRO: Kenneth L. Bielat, PhD)

[ICMIC: 11/07, 3/10, 3/11]

-Medical Imaging Study Section (MEDI), Bethesda, MD (SRO: Eileen Bradley, DSc)(Ad-Hoc Member, 2005-2006, 2011-present; Charter Member, 2007-2011)

[MEDI: 10/05, 2/06, 10/06, 9/07, 6/08, 2/08, 10/08, 2/09, 6/09, 10/09, 2/10, 6/10, 2/11, 6/11]

-Division of Translational and Clinical Division (DTCS) Special Emphasis Panel for Translational Research (SRO: Eileen Bradley, DSc)

[DTCS: 6/12, 2/13]

-Clinical Molecular Imaging and Probe Development (CMIP) Study Section (SRO: Jason Lewis, PhD)

[CMIP: 10/13]

-Special Emphasis Panel (SRO: Kathryn Morton, MD)

[ZRG1 SBIBW 56: 10/13]

-Awards for Research on Imaging and Biomarkers for Early Cancer Detection (SRO: Thomas Winters, PhD)

[2014/05 ZCA1 SRLB-J (M3) S: 3/14]

 

Cancer Prevention Research Institute of Texas (CPRIT)

-Imaging Technology and Informatics Review Panel (2014-)

 

Pennsylvania Department of Health’s CURE Program

-Final Performance Review – 12-13 Cycle B (January 2013)

 

The American Cancer Society

-USC Institutional Grants (2014-)

 

Radiological Society of North America

-Alexander R. Margulis Award for Scientific Excellence Nominating Committee (2014-2015)

 

Scientific and Medical Conferences
-American College of Nuclear Physicians/Medicine Annual Meeting (2006-2014)
-Society of Nuclear Medicine: Instrumentation and Data Analysis Track Educational Exhibits (2005)
-Society of Nuclear Medicine: Oncology - Clinical Diagnosis (2006-2013)

-World Congress of Molecular Imaging (2009, Cancer Imaging Co-Chair 2010, 2011)

Scientific and Medical Journals
-American Journal of Roentgenology (2000-present)
-Aviation, Space and Environmental Medicine (2000)
-Clinical Medicine and Research (2002-present)
-European Journal of Haematology (2003)
-European Journal of Nuclear Medicine and Molecular Imaging (2007-present)
-Haematologica (2003)
-IEEE Transactions on Biomedical Engineering (1988)
-Journal of Computer Assisted Tomography (2002-present)
-Journal of Nuclear Medicine (2000-present)

-Journal of Urology (2013-present)

-Lancet (2013- present)

-Molecular Imaging (2005-present)
-Molecular Imaging and Biology (2004-present)

-Nature Reviews Oncology (2008)

-Nature Reviews Urology (2008)
-Neoplasia (2002)

-Prostate Cancer and Prostatic Diseases (2013-)
-Radiology (2002-present)

 

The Robert E. and Mary R. Wright Foundation Pilot Grant Programs

-University of Southern California (May 2013)

 

University Administration

-Harvard College Admissions Interviewer, Cambridge, MA (2008-present)

University Service Activity:

University of Chicago, Chicago, IL (1990-1991)
-Founder, Biological Sciences Division Student Research Forum (a University Recognized Student Organization)

University of Southern California, Los Angeles, CA(July1999- present)

-Academic Leadership and Development (ALD) Committee (Sept 2008-2011)

-Clinical Nuclear Medicine Protocols Revision (1999-2000)
-Continuous Quality Improvement, Division of Nuclear Medicine, LAC+USC  Medical Center (1999-2000)
-Nuclear Medicine Graduate Medical Education Committee (June-November 2000)
-Health Sciences Campus Radiation Safety Committee (August 2000-present)

-Radioactive Drug Research Committee (July 2007-present)
-Radiology Research Committee, Department of Radiology (April 2002-present)
-Radiology Industry-Sponsored Clinical Trial Workshop, Department of Radiology (April 2002)
-Chair, Radiology Educational Materials Workshop, Department of Radiology (July 2002)
-Radiology Internal Promotions Review Committee (2005)
-Norris Comprehensive Cancer Center Developmental Therapeutics Research Program Committee (June 2004-present)
-Biomedical Imaging Science Initiative Committee - Education Subcommittee Leader (July 2007)
-Molecular Imaging Center Steering Committee (July 2007-present)

-USC Research Committee (2009-present)

-KSOM Dean’s Research Cabinet (2009- present)

-KSOM Research Seminar Series Committee (2009- present)

-USC Health Sciences Campus Institutional Review Board (IRB) (2010)

-Center for Research Excellence (CER) Faculty Fellow (2007-2010)
CER Research Workshop: Seminar in Translational and Clinical Imaging (October 10, 2007)
CER Research Salon: What Molecular Imaging Can do for Science? (October 31, 2007)

CER Research Salon: Bridging Mouse and Man with Molecular Imaging (October 20, 2008)

CER Research Workshop: Translational and Clinical Imaging; Bridging Mouse and Man with Molecular Imaging (November 2008)

CER Research Workshop: What Can Molecular Imaging Do for My Research? (November 11, 2009)

CER Research Salon: Molecular Imaging: Modalities, Methods, and Utility (December 9, 2009)

-Clinical Investigation Committee (CIC), USC Norris Comprehensive Cancer Center (2013-15)

-Translational Oncology Program (TOP), USC Norris Comprehensive Cancer Center (2014-)

Selected Consulting Activity:

Arzco Medical Electronics, Inc., Vernon Hills, IL (Esophageal Electrocardiography and Cardiac Pacing)(July-September 1989)

Diatide, Inc., Londonderry, NH (Evaluation of the CD-ROM Teaching Module for use of Tc-99m Apticide in Detection of Acute DVT)(October1998)

Tanner Research Labs, Inc., Pasadena, CA (Evaluation of an Internet-based Nuclear Medicine Image Analysis)(September 1999)

Cardiac Science, Inc., Irvine, CA (Cardiac Pacing for Incorporation in an Automatic Defibrillator Module)(August 2000)

WebMD/Medscape, Inc. (Radiology Editorial Advisory Board Member; Author: Conf. Highlights, Clinical CME’s, Radiology View Points)(2002-present)

NASA-Jet Propulsion Laboratory (JPL), Pasadena, CA (Financial model for Spacecraft Navigation Software Services)(April-June 2006) -- (as part of USC Executive MBA Theme V project)

Brookhaven National Laboratory, Upton, NY (PET Imaging of Retinal Prosthesis Functionality) -- (supported by Department of Energy in collaboration with Mark Humayun, MD, PhD, at the USC Doheny Eye Institute)(2006-2008)

 

Cambridge University Press (review of book proposals on molecular imaging and PET-CT)(2007-present)

 

Oxford University Press (review of book proposals on medical imaging)(2008-present)

 

Hollywood, Health & Society (consultant to TV show writers and producers – “House MD”, “CSI”) (2008-2010)

 

Roche (San Francisco, CA - February 2010)

 

Dendreon Corp. (Seattle, WA - February 2012)

 

ACR Image Matrix (Philadelphia, PA – November 2012)

 

Florida International University, Nuclear Board of Advisors for Science and Engineering – NBASE, Chaired by Nils Diaz, former NRC Chair (Miami, FL – January 2013)


PROFESSIONAL AFFILIATIONS


Academy of Persian Physicians (APP), American College of Nuclear Medicine (ACNM), Association of Professors and Scholars of Iranian Heritage (APSIH), American Roentgen Ray Society (ARRS), European Association of Nuclear Medicine (EANM), Institute of Electrical and Electronics Engineers-Engineering in Medicine and Biology Society (IEEE-EMBS), Radiological Society of North America (RSNA), Society of Nuclear Medicine and Molecular Imaging (SNMMI)


HOBBIES & INTERESTS 


Astronomy and Cosmology, Classical Music, Opera, History and Philosophy of Science, Concept of Leadership, Photography, World Travel
Member: National Geographic Society; National Space Society; The Planetary Society; University Alumni Associations of Iowa State, Wisconsin-Madison, Michigan, Chicago (Pritzker), UCSF Medical Alumni, Stanford Radiology, Harvard Club of Southern California, USC Marshall School of Business
Published Photographs (Refereed):
1. "Sleepy Sun" ,New Engl J Med 334(26): 1690; June 27, 1996.
2. "Falling in Love" ,New Engl J Med 338(7): 477; February 12, 1998.
3. "Haleakala Crater, Maui" , Am J Roentgenol AJR 171(5): 1348; November 1998.
4. "Palm Sunset", Am J Roentgenol AJR 171(5): 1380; November 1998.
5. "Gone Fishing", Am J Roentgenol AJR 175(1): 140; July 2000.
6. "Room with a View (North Coast of Aruba)", Am J Roentgenol AJR 177(4): 806; October 2001.
7. "Raw and Ripe" ,Am J Roentgenol AJR 177(4): 886; October 2001.
8. "Joshua Tree National Park, California", Am J Roentgenol AJR 178(1): 110; January 2002.
9. "Alas, Poor Yorick!", Am J Roentgenol AJR 178(1): 178; January 2002.
10 "Death Valley, California", Am J Roentgenol AJR 179(5): 1244; November 2002.
11 "Yosemite, California", Am J Roentgenol AJR 181(8):302; August 2003.
12. "Cancun, Mexico", Am J Roentgenol AJR  181(4):1092; October 2003.


MEDIA NEWS


1. 2000 Tetalman award goes to Jadvar, J Nucl Med Vol. 41, No. 9, page 18N, 2000.
2. USC radiologist honored as outstanding young investigator, HSC Weekly Vol. 6, No. 20, June 23, 2000.
3. PET scans help doctors better evaluate women with cervical cancer, HSC Weekly Vol. 7, No. 35, December 14, 2001.
4. PET scans help doctors better evaluate women with cervical cancer, USC Chronicle Vol. 21, Issue 17, February 4, 2002.
5. USC radiologist receives molecular imaging grant, HSC Weekly Vol. 8, No. 9, March 22, 2002.
6. State of the heart, USC Health Magazine Spring 2002.
7. Female Advantage, USC Health Magazine Summer 2002.
8. Wright Foundation bolsters USC research with $600,000 in grants, HSC Weekly Vol. 8, No. 29, October 18, 2002.
9. ACNM honors Jadvar, HSC Weekly Vol. 9, No. 14, April 25, 2003; USC Chronicle Vol. 22, No. 31, May 26, 2003.
10. ACNP honors Jadvar, HSC Weekly Vol. 11, No. 1, January 7, 2005.
11. Imaging marches forward, ACNP Scanner  pp. 6-7, July/August 2005.
12. USC radiologist receives $3.3 million for study of combination PET-CT scans for prostate cancer, HSC Weekly Vol. 11, No. 23, July 29, 2005.
13. Jadvar receives $3.3 million NIH/NCI grant, RSNA News Vol. 15, No. 8, page 2, August 2005.
14. Sunshine superman -- Improving evaluation, USC/Norris Comprehensive Cancer Center Report Fall 2005.
15. Radiologist to further study of cancer, USC News November 21, 2005; USC Chronicle January 20, 2006.
16. Call for prostate cancer patients - Radiology professor seeks participants for an experimental study, USC News September 22, 2006.
17. Molecular imaging modernizes medicine, Biotechnology Healthcare February 2007.
18. Helping faculty find collaborators: First six fellows of Center for Excellence in Research plan to reach out across campus to mentor new researchers, USC Chronicle Vol. 26, No. 19. 31, June 4, 2007.
20. USC Center for Excellence in Research taps HSC talentHSC Weekly Vol. 13, No. 19, June 22, 2007.
21. Nuclear Medicine Explained, VideoJug, September 2007.
22. Hossein Jadvar selected as a Charter Member of National Institutes of Health (NIH) Medical Imaging (MEDI) Study Section, HSC Weekly, October 19, 2007.

23. Live Radio Interview, Association of Professors and Scholars of Iranian Heritage (APSIH), KIRN 670 AM, Los Angeles, February 29, 2008.

24. WebCast Lecture, USC Radiology Student Interest Group (RSIG), September 8, 2008.

25. Etcetera: Hossein Jadvar, named president of the Pacific Southwest Chapter of the Society of Nuclear Medicine (SNM), HSC Weekly, March 27, 2009.

26. No more lonely scientists, USC Keck Medicine Magazine, Summer 2009.

27. Molecular Imaging Role’s in Prostate Cancer, Molecular Imaging Insight, December 2009.

28. Top Doctors 2010, Radiology, Pasadena Magazine, p. 66, June 2010.

29. Western Regional Society of Nuclear Medicine honors Hossein Jadvar, Keck School of Medicine News and Notes, September 15, 2010.

30. Etcetera - Western Regional Society of Nuclear Medicine honors Hossein Jadvar, HSC Weekly, December 10, 2010.

31. Live Radio Interview, Prostate Cancer Symposium, KIRN 670 AM, December 4, 2010.

32. Physicians Receive SNM Awards, RSNA News Vol. 20, No. 12, December 2010.

33. Jadvar Receives Nuclear Medicine Award, USC Chronicle Vol. 30, No. 21, February 21, 2011.

34. Live Radio Interview, Association of Professors and Scholars of Iranian Heritage (APSIH), KIRN 670 AM, Los Angeles, October 2, 2011.

35. Etcetera: Hossein Jadvar, named president-elect of the SNM PET Center of Excellence and the American College of Nuclear Medicine, HSC Weekly, March 2, 2012.

36. Jadvar Elected Vice President of PET Center of Excellence, USC Chronicle, April 9, 2012.

37. Jadvar Named ACNM President. RSNA News Vl 23, No 5, May 2013.

38. Interview – Can the Academic Survive the Academic Medicine? By: Brown T.  SNMMI Academic Council Newsletter; May 2013. [Article]

39. Joint NCI/SNMMI Workshop on Targeted Radionuclide Therapy.  J Nucl Med 2013 54:16N-17N. [Article] [Audio Presentation]

40. Interview – Are Radiopharmaceuticals in their element?, By: Ryerson N. DOTmedbuisiness News; June 2013.

41. Quantitative PET/CT could improve prostate cancer treatment? By: KF Mahdoubi. Molecular Imaging; June 2013.

42. SNMMI Elects Hossein Jadvar, MD, PhD, MPH, MBA, FACNM, as Vice-President-Elect during 2013 Annual Meeting. SNMMI Press Release; June 10, 2013.

43. New Officers for SNMMI and SNMMI-TS. J Nucl Med 54(7): 9N-10N; 2013. [Article]

44. Hossein Jadvar named vice president-elect of the Society of Nuclear Medicine and Molecular Imaging. HSC Weekly, June 7, 2013.

45. SNMMI Names Officers, Bestows Awards. RSNA News. Vol. 23, No. 10 & 11, October-November 2013.

46. YouTube: “State of the Art Conference on Prostate and Kidney Cancers, Amsterdam, The Netherlands – Interview with Dr. Hossein Jadvar”, September 2013.

47. The Academy of Radiology Research Announces the Recipients of its Third Annual Distinguished Investigator Award, June 2014.

48. Leading radiology organization awards grants to Keck School students, July 2014.

49. Molecular Imaging: Will PET/MR ever get to PET/CT’s level? By: L Dubinsky. DOTmedbuisiness News; June 2014.

50. SNMMI Elects Hossein Jadvar, MD, PhD, MPH, MBA, FACNM, as President-Elect during 2014 Annual Meeting, SNMMI Press Release; June 9, 2014; J Nucl Med 55(8):13N.

51. Interview -- “The Future of Cancer Treatment with Hossein Jadvar”, By: Ruck S. HealthCareBusiness News, www.dotmed.com, September 2014.


RESEARCH PROPOSALS 


Principal Investigator, "Activity and size estimation of the striatum dopamine transporter density with SPECT imaging", Harvard Medical School Joint Program in Nuclear Medicine, $7000; 08/01/98-06/30/99. (20% effort)

Principal Investigator, "Perfusion and functional characterization of coronary collaterals: implications on myocardial viability assessment", Society of Nuclear Medicine Pilot Research Grant, $4500; 07/01/00-06/30/02. (25% effort)

Principal Investigator, "Discrimination of inflammation from malignancy with dynamic FDG-PET kinetic analysis", American Cancer Society, IRG-58-007-43, $19,931; 07/01/00-06/30/02. (IRB#009004) (20% effort)

Principal Investigator, "Role of oxidative metabolism in cancer: validation study with C-14 acetate autoradiography in rats", Radiological Society of North America Research and Education Fund Seed Grant, $29,831; 03/01/02-02/29/03. (25% effort) [RSNA Announcement Online] [USC HSC Weekly Announcement Online]

Principal Investigator, "Pre-clinical study of choline in human prostate cancer xenografts: preliminary data to support in-vivo imaging with choline PET", The Wright Foundation, $50,000; 7/1/02-6/30/04 extended to 6/30/07. (20% effort)

Consultant, "Prediction of cardiomyopathy in type 1 diabetes by 31P MRS", National Institutes of Health--National Heart, Lung and Blood Institute, PI: G. Pohost; $2,013,412; 8/15/02-07/31/07. (5% effort) (R01-HL73412)

Principal Investigator, "FDG PET-CT evaluation of metastatic prostate cancer", National Institutes of Health--National Cancer Institute , $3,295,020; 7/1/05-5/31/11. (40% effort) (Priority Score 130)(No-cost Extension to 12/31/13) (R01-CA111613)

Co-Investigator, "Biomedical imaging informatics training program”, PI: H. Huang, National Institutes of Health-- National Institute of Biomedical Imaging and Bioengineering, $1,600,000; 9/1/05-8/31/10. (5% effort)(T32-EB004308)

Co-Investigator, "PET imaging of hypoxia in prostate cancer", PI: A. Nacca, American Cancer Society, $20,000; 7/1/07-6/30/09. (5% effort - no salary)

Principal Investigator, “[F-18]-FMAU PET in prostate cancer”, National Institutes of Health--National Cancer Institute, $393,250; 9/1/09-8/31/11 (20% effort)(Priority Score 170) )(No-cost Extension to 8/31/12)(R21-CA142426) [Funded by the American Recovery and Reinvestment Act of 2009]

 

Co-Investigator, “Antibiotic Modulation of Staphylococcal Virulence Expression and Its Impact on Disease Severity in Murine Model of Infection”, Southern California Clinical and Translational Science Institute (SC CTSI), PI: A. Wong-Beringer, $30,000; 3/1/13-2/28/14 (5% effort)

 

Principal Investigator, “Pilot human studies of FMAU PET in prostate cancer”, Whittier Foundation, $25,000; 9/1/13-12/31/14 (10% effort)

 

Principal Investigator, “Disintegrin PET of Prostate Cancer”, Southern California Clinical and Translational Science Institute, $42,500; 7/1/14-6/30/15 (10% effort)

 

Co-Investigator, “Biological impact of fluoroquinolone resistance in P. aeruginosa”, National Institutes of Health, PI: A. Wong-Beringer  (5% effort)(In Review)

 

Principal Investigator, “Multi-Integrin PET of Prostate Cancer with Vicrostatin”, National Institutes of Health--National Cancer Institute, R21 mechanism, 2014 (10% effort)(In Review)


PATENTS (Total 9)


1.        Jadvar H, Arzbaecher RC: "Artifact Suppressing Apparatus and Method", International Patent #WO/1989/009514, May 10, 1989.

2.        Metzger WT, Jadvar H: "Variable Stiffness Esophageal Catheter". U.S. Patent #4,930,521, June 5, 1990; European Patent #EP473598A1, January 21, 1992.

3.        Jadvar H, Arzbaecher RC: "Method and Apparatus for Detection of Posterior Ischemia". U.S. Patent #5,010,888, April 30, 1991.

4.        Jadvar H, Metzger WT: "Multiple-Electrode Affixable Sheet".  U.S. Patent #5,069,215, December 3, 1991; U.S. Patent #5,109,851, May 5, 1992; European Patent #EP381816A2, August 16, 1990; European Patent #EP381816A3, November 7, 1990.

5.        Metzger WT, Jadvar H: "Expandable Esophageal Catheter". U.S. Patent #5,117,828, June 2, 1992.


PUBLICATIONS


THESES

 

1.        Jadvar H: "The implementation and evaluation of a calibration system for Type T thermocouples in whole body hyperthermia", M.S. Thesis , Biomedical Engineering Program, University of Wisconsin-Madison;1984.

2.        Jadvar H: "Computer analysis of the electrocardiogram for detection of myocardial ischemia during transesophageal atrial pacing stress", Ph.D. Dissertation, Bioengineering Program, University of Michigan, Ann Arbor; 1988. (Dissertation Abstracts International, Vol. 49, No. 8, 1989) [Abstract]

BOOKS

1.        Jadvar H, Parker JA: Clinical PET and PET/CT, Springer-Verlag, Inc., London, UK; 2005. (ISBN 1-85233-838-5)---Foreword by Sanjiv Sam Gambhir, M.D., Ph.D., Stanford University, Stanford, CA. (Bestseller at the 2005 Congress of the European Association of Nuclear Medicine, Istanbul, Turkey)(Translated into Turkish by Nobel Tip Kitabevleri Ltd., 2007) [Book Review - Eur J Radiol] [Book Review - J Nucl Med]

2.        Jadvar H (Guest Ed.): Molecular Imaging of Prostate Cancer, PET Clinics, Elsevier, Inc., New York, NY; 2009. (ISSN 1558-8598) [NIH-NCI R01-CA111613-01 Support]

3.        Graham M, Jacene H, Jadvar H: Molecular Imaging, Cambridge University Press, Cambridge, UK; 2014. (In Preparation)

BOOK CHAPTERS

1.        Lin C-H, Jadvar H: "Interfacing temperature sensors", In: Interfacing Sensors to the IBM PC, WJ Tompkins and JG Webster (eds.), Prentice-Hall, Inc., Englewood Cliffs, NJ, Chapter 7, pp. 183-224; 1988. (ISBN 0-13-469081-8)

2.        Jadvar H, Arzbaecher RC: "Temporary esophageal pacing", In: Temporary Cardiac Pacing, CE Bartecchi and DE Mann (eds.), Precept Press, Inc., Chicago, IL, Chapter 11, pp. 146-190; 1990. (ISBN 0-944496-12-1)

3.        Mindelzun RE, Jadvar H: "The peritoneum, retroperitoneum and the fascial planes", In: Variants and Diagnostic Pitfalls in Body Imaging , A Shirkhoda (ed.), Lippincott Williams & Wilkins, Philadelphia, PA., Chapter 16, pp. 333-353; 2000. (ISBN 0-683-30058-X)

4.        Jadvar H, Fischman AJ: "Scintigraphy of neoplastic disease: positron imaging of tumors", In: Teaching Atlas of Nuclear Medicine, KJ Donohoe and A Van den Abbeele (eds.), Thieme Medical Publishers, Inc., New York, NY, Chapter V(E), pp. 247-265; 2000. (ISBN 0-86577-775-6)

5.        Jadvar H, Connolly LP, Shulkin BL, Treves ST, Fischman AJ: "Positron emission tomography in pediatrics", In: Nuclear Medicine Annual , LM Freeman (ed.), Lippincott Williams & Wilkins, Philadelphia, PA, pp. 53-83; 2000. (ISBN 0-7817-2573-9, ISSN 0272-0108)

6.        Jadvar H, Conti PS: "Molecular imaging: frontier of molecular medicine and imaging science", In: Biotechnology International III , BN Alizadeh (ed.), Universal Medical Press, Inc., San Francisco, CA, pp. 293-298; 2001. (ISBN 1-890131-02-4, ISSN 1094-9984)

7.        Jadvar H, Connolly LP, Shulkin BL: "Pediatrics", In: Principles and Practice of Positron Emission Tomography, Wahl RL (ed.), Lippincott Williams & Wilkins, Philadelphia, PA, pp. 395-410; 2002. (ISBN0-7817-2904-1)

8.        Jadvar H, Connolly LP, Shulkin BL: "PET imaging in pediatric disorders", In: Positron Emission Tomography: Basic Science and Clinical Practice , Valk PE, Bailey DL, Townsend DW, Maisey MN (eds.), Springer-Verlag, London, UK, pp. 755-774; 2003. (ISBN 1-85233-485-1)

9.        Jadvar H: "Ch 5-Breast cancer, Ch 6-Gynecologic malignancies, Ch 9-Esophageal carcinoma, Ch10-Gastric cancer, Ch 17-Lung tumors, Ch 24-Ovarian cancer, Ch26-Prostate cancer", In: PET-CT: A Case-Based Approach ,Conti PS, Cham DK (eds.), Springer-Verlag, Inc., New York, NY; 2005. (ISBN0-387-20858-5)

10.     Jadvar H, Connolly LP, Fahey F, Shulkin BL: "PET imaging in pediatrics", In: Positron Emission Tomography in Clinical Practice, Valk PE, Delbeke D, Bailey DL, Townsend DW, Maisey MN (eds.), Springer-Verlag, Inc., London, UK, pp. 337-357; 2006.--In memory of Peter Valk, M.D. (ISBN-10: 1-852339713)

11.     Jadvar H, Shulkin BL: "Pediatric oncology", In: Pediatric Nuclear Medicine,  3rd ed. Treves ST (ed.), Springer-Verlag, New York, NY, pp. 404-418; 2007. (ISBN-10: 0-387-32321-X)

12.     Jadvar H, Conti PS: "Ch 47: PET and PET-CT in kidney tumors and bladder cancer", In: Clinical Molecular Anatomic Imaging: PET, PET/CT, and SPECT/CT, Von Schulthess GK (ed.),  Lippincott Williams & Wilkins, Philadelphia, PA, pp. 413-416; 2007. (ISBN 0-7817-7674-0)

13.     Boswell WD Jr., Jadvar H, Palmer SL: "Diagnostic kidney imaging", In: Brenner and Rector's The Kidney, 8th ed.  Brenner BM (ed.), Saunders Elsevier Inc., Philadelphia, PA, Chapter 27, pp. 839-914; 2008 - 9th ed.; 2010 (10th ed. updated material submitted Feb 2014)

14.     Jadvar H, Connolly LP, Fahey F, Shulkin BL: "Pediatrics", In: Principles and Practice of Positron Emission Tomography, 2nd Edition, Wahl RL (ed.), Lippincott Williams & Wilkins, Philadelphia, PA; pp. 443-463; 2009.

15.     Jadvar H: "Role of FDG PET and PET-CT in oncology", In: Principles and Practice of Surgical Oncology: Multidisciplinary Approach to Difficult Problems, Silberman H, Silberman AW (eds.), Lippincott Williams &Wilkins, Philadelphia, PA, Chapter 9, pp. 167-184; 2009. (ISBN 0-7817-6546-3)---Commentary by Alan D. Waxman, M.D., Cedars-Sinai Medical Center, Los Angeles, CA.

16.    Jadvar H: “Prostate cancer”, In: Positron Emission Tomography:  Methods of Molecular Biology, Juweid M, Hoekstra O (eds.), Springer Science+Business Media, LLC, pp. 265-290; 2011. [NIH-NCI R01-CA1116101 and R21-CA142426 Support]

17.     Jadvar H, Fahey F, Shulkin BL: "Pediatric”, In: Medical Radiology Diagnostic Imaging Series: PET-CT and PET-MRI  in Oncology – A Practical Guide, Peller P,  R. Subramaniam, and  A. Guermazi (eds.), Springer-Verlag, Inc., New York, NY, pp. 253-277; 2012. (ISBN 978-3-642-01138-2)

18.    Kauffman E, Ng C, Jadvar H: “Chapter 17: Molecular imaging in diagnostics”, In: Prostate Cancer: A Comprehensive Perspective, Vaughan D, Neal D, Eastham J, Fitzpatrick J, Costello A, Sooriakumaran P, Sampaio F, Desai M (eds.), Springer, Inc., New York, NY, 2012.  [NIH-NCI R01-CA1116101 and R21-CA142426 Support]

19.     Desai B, Jadvar H: "Gynecologic Malignancies; Urologic Malignancies", In: PET-CT: A Case-Based Approach ,Conti PS, Cham DK (eds.), Springer-Verlag, Inc., New York, NY; 2012. (In Press)

20.     Jadvar H: “Radionuclide imaging of cancer therapy”, In: Cancer Theranostics, Wong S, Chen X (eds.), Elsevier, Inc. New York, NY; pp. 45-54; 2014. (ISBN: 978-0-12-407722-5)

21.     Jadvar H, Ballas L, Quinn DI: “Chapter 19.6: Treatment of bone metastases: Radiopharmaceuticals”, In: Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management, Dicker AP, Kelly WK, Trabulsi EJ, Zaorsky NG (eds.), Demos Medical Publishing, New York, NY; pp. 375-384; 2015. (ISBN: 9781936287598)  [NIH-NCI R01-CA1116101 and R21-CA122426 Support]

22.     Jadvar H, Conti PS: "PET/CT and PET/MRI in kidney tumors and bladder cancer", In: Clinical Molecular Anatomic Imaging: PET, PET/CT, and SPECT/CT, Von Schulthess GK (ed.), 2nd ed. Lippincott Williams & Wilkins, Philadelphia, PA. (Submitted)

23.     Jadvar H: “Prognostic utility of PET in prostate cancer”, In: PET Clinic: PET/CT and Patient Outcomes in Oncology, Part I, Subramaniam R (ed.), Elsevier, Inc., New York, NY; 2014. (Submitted)

24.     Jadvar H, Shulkin B: “Other Cancers”, In: Clinical Nuclear Medicine in Pediatrics, Manci L, Lopci E, Chiti A (eds.), Springer, Inc., New York, NY, 2015. (Submitted)

JOURNAL ARTICLES (Peer-Reviewed)

1.         Jadvar H, Jenkins JM: "Lead configurations in esophageal electrocardiography", Med Instrum 21(3):158-165; 1987. [Abstract]

2.         Quaal SJ, Phillips B, Howry T, Jadvar H: "The pill electrode: new technology as an adjunct to nursing assessment of patient arrhythmias", Prog Cardiovasc Nurs 4(1):10-17; 1989. [Abstract]

3.         Jadvar H, Jenkins JM, Arzbaecher RC: "A system for simultaneous esophageal atrial pacing and ventricular recording in computer analysis of posterior ischemia"J Electrocardiology 22(Suppl):248-252; 1989. [Abstract]

4.         Jadvar H, Gober JR, Schaefer S, Schwartz GG, Weiner MW, Massie BM: "Potential utility of esophageal pacing during cardiac magnetic resonance studies", Am J Electromed 20:134-137; 1989.

5.         Benson DW Jr, Jadvar H, Strasburger JF: "Utility of a stimulus artifact suppressor for transesophageal pacing", Am J Cardiol 65:393-394; 1990.

6.         Chin RB, Madsen EL, Zagzebski JA, Jadvar H, Wu X-K, Frank GR: "A reusable perfusion supporting tissue-mimicking material for ultrasound hyperthermia phantoms", Med Phys 17(3):380-390; 1990. [Abstract]

7.         Jadvar H, Jenkins JM, Stewart RE, Schwaiger M, Arzbaecher RC: "Computer analysis of the electrocardiogram during esophageal pacing cardiac stress", IEEE Trans Biomed Eng 38(11):1089-1099;1991. (IEEE Log #9103281) [Abstract]

8.         Jadvar H, Mindelzun RE: "Endoscopic retrograde cholangiopancreatography", Contemp Diagn Radiol, Williams & Wilkins, Baltimore, MD, 19(18):1-6;1996. (Invited Review Article) (ISSN 0149-9009)

9.         Jadvar H, Mindelzun RE, Olcott EW, Levitt DB: "Still the great mimicker: abdominal TB", Am J Roentgenol AJR 168(6):1455-1460; 1997. [Abstract]

10.      Phillips JR, Jadvar H, Sullivan G, Lin V, Segall GM: "Effect of radionuclide renograms on treatment of patients with spinal cord injuries", Am J Roentgenol AJR 169(4): 1045-1047; 1997. (Cited in: Year Book of Nuclear Medicine 1999, Gottschalk A, Balufox MD, Coleman RE, Strauss HW, Zubal IG (eds.), Mosby Inc., St. Louis, MO, Chapter5, pp. 207-208, ISBN 0-8151-3822-9). [Abstract]

11.      Jadvar H, Segall GM: "False-negative fluorine-18-FDG PET in metastatic carcinoid", J Nucl Med 38(9):1382-1383; 1997. [Abstract]

12.      Jadvar H, McDougall IR, Segall GM: "Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography", Nucl Med Commun 19(6):547-554;1998. [Abstract]

13.      Jadvar H, Mindelzun RE: "Annular pancreas in adults: imaging features in seven patients", Abdom Imaging 24(2):174-177;1999. [Article]

14.      Jadvar H, Strauss HW, Segall GM: "SPECT and PET in the evaluation of coronary artery disease", Radiographics 19(4):915-926;1999. [Article]

15.      Jadvar H, Fischman AJ: "Evaluation of rare tumors with [F-18]fluorodeoxyglucose positron emission tomography", Clin Positron Imaging 2:153-158; 1999. [Abstract]

16.      Jadvar H, Schambye RB, Segall GM: "Effect of atropine and sincalide on the intestinal uptake of F-18 fluorodeoxyglucose", Clin Nucl Med 24(12):965-967; 1999. [Abstract]

17.      Jadvar H, Johnson DL, Segall GM: "The effect of fluorine-18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma", Clin Nucl Med 25(1):48-51; 2000. [Abstract]

18.      Jadvar H: "Medical imaging in microgravity", Aviat Space Environ Med 71(4): 640-646; 2000. [Abstract]

19.      Tatlidil R, Luther S, West A, Jadvar H, Kingman T: "Comparison of fluorine-18 deoxyglucose and O-15 water PET in temporal lobe epilepsy", Acta Neurol Belg 100(4):214-220; 2000. [Abstract]

20.      Krausz Y, Ikeda DM, Jadvar H, Langleben D, Birdwell R, Strauss HW: "Non-visualization of sentinel lymph node in patients with breast cancer", Nucl Med Commun 22(1):25-32; 2001. [Abstract]

21.      Jadvar H, Fischman AJ: "Evaluation of pancreatic carcinoma with FDG PET", Abdom Imaging 26:254-259; 2001. [Abstract]

22.      Kijewski MF, Moore SC, Jadvar H, Zimmerman RE, Müller SP: "Effects of SPECT collimation and system geometry on classification tasks related to Parkinson's disease", IEEE Trans Nucl Sci 48:734-738; 2001.

23.      Saremi F, Jadvar H, Siegel ME: "Pharmacologic interventions in nuclear radiology: indications, imaging protocols, and clinical results", Radiographics 22:477-490; 2002. [Article]

24.      Tatlidil R, Jadvar H, Bading JR, Conti PS: "Incidental colonic [F-18]fluorodeoxyglucose uptake: correlation with colonoscopy and histopathology", Radiology 224:783-787; 2002. [Article]

25.      Parker JA, Wallis JW, Jadvar H, Christian P, Todd-Pokropek A: "Procedure guideline for telenuclear medicine 1.0", J Nucl Med 43(10):1410-1413; 2002. [Article]

26.      Jadvar H, Conti PS: "Diagnostic utility of FDG-PET in multiple myeloma", Skeletal Radiol 31(12):690-694; 2002. [Article]

27.      Jadvar H, Tatlidil R, Garcia AA, Conti PS: "Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission  tomography", Clin Radiol 58(3):215-221; 2003. [Article]

28.      Jadvar H, Pinski JK, Conti PS: "FDG PET in suspected recurrent and metastatic prostate cancer", Oncol Rep 10(5):1485-1488;2003. [Article]

29.      Jadvar H, Shulkin BL: "Advances in imaging of nonthyroid endocrine neoplasms", Problems in General Surgery: Nonthyroid Endocrine Surgery , Brunt LM (ed.), Lippincott Williams & Wilkins, Philadelphia, PA, 20(3):11-20; 2003.

30.      Jadvar H, Kherbache HM, Pinski JK, Conti PS: "Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma", Clin Nephrol 60(6): 395-400; 2003. [Abstract]

31.      Jadvar H, Gamie S, Ramanna L, Conti PS: "Positron Emission Tomography (PET) III: Musculoskeletal system", Semin Nucl Med 34(4):254-261; 2004. (Invited Review Article) [Article]

32.      Jadvar H, Conti PS: "Positron Emission Tomography (PET) III: The reproductive tract", Semin Nucl Med 34(4): 262-273; 2004. (Invited Review  Article) [Article]

33.      Jadvar H, Alavi A, Mavi A, Shulkin BL: "PET in pediatric diseases", In: Radiol Clin N Am, Alavi A (ed.), Elsevier Saunders Inc., Philadelphia, PA; 43(1):135-152; 2005. (ISSN 0033-8389) (Invited Review Article) [Abstract]

34.      Jadvar H, Li X, Shahinian A, Park R, Tohme M, Pinski J, Conti PS: "Glucose metabolism of human prostate cancer mouse xenografts", Mol Imaging 4(2):91-7; 2005. [Abstract]

35.      Jadvar H, Henderson RW, Conti PS: "2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography imaging evaluation of esophageal cancer", Mol Imaging Biol 8(3):193-200; 2006. (Featured in "From the Literature" in the Journal of Nuclear Medicine 47:43N; 2006) [Abstract]

36.      Jadvar H, Henderson RW, Conti PS: "[F-18]fluorodeoxyglucose PET and PET-CT in recurrent and metastatic cholangiocarcinoma", J Comput Assist Tomogr 31(2):223-228, 2007.  [Abstract]

37.      Jadvar H, Connolly LP, Fahey F, Shulkin BL: "PET and PET/CT in pediatric oncology", Semin Nucl Med 37:316-331; 2007. (Invited Review Article) [Article]

38.      Janne d’Othée B, Siebert U, Jadvar H, Dunn EJ, Hoffman U: "A systematic review on diagnostic accuracy of CT-based detection of significant coronary artery disease", Eur J Radiol  65(3):449-61; 2008. [Abstract]

39.      Jadvar H, Quan V, Henderson RW, Conti PS: "[F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma", Int J Clin Oncol 13(1):42-47; 2008. [Abstract] (Highlighted on Journal Cover) [NIH-NCI R01-CA111613 Support]

40.      Jadvar H, Ye W, Groshen S, Conti PS: "[F-18]-Fluorodeoxyglucose PET-CT of normal prostate gland", Ann Nucl Med 22(9):787-93; 2008. [Abstract] [NIH-NCI R01-CA1116131 Support]

41.      Jadvar H, Gurbuz A, Li X, Shahinian A, Conti PS: “Choline autoradiography of human prostate cancer xenograft: effect of castration”, Mol Imaging 7(3):147-152; 2008. [Abstract] [NIH-NCI R01-CA111613 Support]

42.      Jadvar H: “Molecular imaging of prostate cancer: a concise synopsis”, Mol Imaging 8(2):56-64; 2009. [Article] [NIH-NCI R01-CA111613 Support]

43.      Iagaru A, Kundu R, Jadvar H, Nagle D: “Evaluation by 18F-FDG-PET of patients with anal aquamous cell carcinoma”, Hell J Nucl Med; 2009. [Abstract]

44.      Jadvar H: “Molecular imaging of prostate cancer with [F-18]-fluorodeoxyglucose PET”, Nat Rev Urol 6(6):317-323; 2009. (Invited Review Article) [Abstract] [NIH-NCI R01-CA111613 Support]

45.      Jadvar H, Alavi A, Gambhir SS: “[F18]-fluorodeoxyglucose uptake in lung, breast and colon cancers: molecular biology correlates and disease characterization”, J Nucl Med 50: 1820-1827; 2009.  (Invited Review Article) [Article] [NIH-NCI R01-CA111611 Support]

46.      Jadvar H, Alavi A: “Role of imaging in prostate cancer”, PET Clinics 4(2):135-138; 2009. [Article] [NIH-NCI R01-CA111613 Support]

47.      Jadvar H: “FDG-PET in prostate cancer”, PET Clinics 4(2):155-161; 2009. [Article]  [NIH-NCI R01-CA111613 Support]

48.      Lin E, Wang Q, Swenson S, Jadvar H, Groshen S, Ye W, Markland FS, Pinski J: “The disintegrin contotrostatin with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo”, Prostate 26;70(12):1359-1370; 2010. [Abstract] [NIH-NCI R01-CA111613 Support]

49.      Xie J, Wang G-J, Cela CJ, Humayun Ms, Weiland J, Lazzi G, Jadvar H: “Modeling and percept of trancorneal electrical stimulation in humans”, IEEE Trans Biomed Eng 58(7):1932-9; 2010. [Abstract]

50.      Yu F, Huang J, Adlerz K, Jadvar H, Chen J-N, Hsiai TK: “Micropipette electrocardiogram to assess conduction phenotypes in zebrafish larvae”, Zebrafish 7(4):325-31; 2010. [Abstract]

51.      Jadvar H: “Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline”, J Nucl Med 52(1):81-9; 2011. (Invited Review Article)(Top 25 most read JNM article, June 2011) [Abstract] [NIH-NCI R01-CA1116101 and R21-CA142426 Support]

52.      Jadvar H: “Colonic FDG uptake pattern in subjects receiving oral contrast with no known or suspected colonic disease”, Clin Nucl Med 36(9):754-756; 2011. [Abstract]

53.      Scott-Hunter M, Henkin RE, Del Rowe JD, Grigsby PW, Hartford AC, Jadvar H, Macklis RM, Parker JA, Wong JYC, Rosenthal SA: “ACR-ASTRO Practice Guideline for the Performance of Therapy with Unsealed Radiopharmaceutical Sources”, Clin Nucl Med 36: e72–e80; 2011. [Abstract]

54.      Xie J, Wang G-J, Yow L,  Humayun M, Weiland JD, Cela CJ, Jadvar H, Lazzi G, Gavazi E, Tsang SH: “Preservation of retinopathic map in retinal degeneration”, Exp Eye Res 98:88-96; 2012. [Abstract]

55.      Jadvar H: “Hepatocellular carcinoma and gastroenteropancreatic tumors: potential role of other positron emission tomography radiotracers”, Semin Nucl Med; 42(4):247-54; 2012. (Invited Review Article) [Abstract]

56.      Jadvar H, Desai B, Ji L, Conti P, Dorff T, Groshen S, Gross M, Pinski J, Quinn D: ”Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer”, Clin Nucl Med 37(7):637-643; 2012. [Abstract]  [NIH-NCI R01-CA1116101 Support]

57.      Jadvar H: “Molecular Imaging of Prostate Cancer - PET Radiotracers”, AJR Am J Roentgenol 199(2):278-9; 2012. (Invited Review Article) [Abstract] [NIH-NCI R01-CA1116101 and R21-CA142426 Support]

58.      Jadvar H, Yap L-P, Park R, Li Z, Chen K, Hughes L, Kouhi A, Conti P: “[18F]-2’-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Mouse Models of Implanted Human Prostate Cancer Xenografts: Initial Preclinical Observations”, Mol Imaging 11(5):426-32; 2012. [Abstract] [NIH-NCI R21-CA142426 Support]

59.      Siberstein EB, Alavi A, Balon HR, Clarke SEM, Divgi C, Gelfand MJ, Goldsmith SJ, Jadvar H, Marcus CS, Martin WH, Parker JA, Royal HD, Sarkar SD, Stabin M, Waxman AD: “The SNM Practice Guideline for Therapy of Thyroid Disease with 131I 3.0”, J Nucl Med 53(10):1-19; 2012. [Abstract]

60.      Castellucci P, Jadvar H: “PET/CT in prostate cancer: non-choline radiopharmaceuticals”, Q J Nucl Med Mol Imaging 56(4):367-74; 2012. (Invited Review Article) [Abstract] [NIH-NCI R01-CA1116101 and R21-CA142426 Support]

61.      Jadvar H: “Imaging evaluation of prostate cancer with 18F-flurodeoxyglucose PET/CT: utility and limitations”, Eur J Nucl Med Mol Imaging 40 Suppl 1:5-10; 2013. (Invited Review article) [Abstract] [NIH-NCI R01-CA111610 and R21-CA142426 Support]

62.      Jadvar H, Desai B, Ji L, Groshen S, Conti P, Dorff T, Pinski J, Quinn D: “18F-flurodeoxyglucose PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer”, J Nucl Med 54(8):1195-201; 2013. [Abstract] [NIH-NCI R01-CA111610 Support]

63.      Jadvar H: “MI Focus: Molecular imaging of prostate cancer with PET”, J Nucl Med 54(10):1685-1688; 2013. (Invited Review Article) [Abstract] [NIH-NCI R01-CA111610 and R21-CA142426 Support]

64.      Jadvar H, Quinn D: “Targeted alpha therapy of bone metastases in prostate cancer”, Clin Nucl Med 38(12):966-71; 2013. (Invited Review Article) [Abstract] [NIH-NCI R01-CA111610 and R21-CA142426 Support]

65.      Parker JA, Christian P, Jadvar H, Sattler B, Wallis JW: “The SNMMI and EANM Practice Guideline for Tele-Nuclear Medicine 2.0”, J Nucl Med Technol; 2013. [Abstract] [Epub Ahead of Publication]

66.      Jadvar H, Colletti PM: “Competitive advantage of PET/MRI”, Eur J Radiol 83(1):84-94; 2014. (Invited Review Article) [Abstract] [NIH-NCI R01-CA111610 and R21-CA142426 Support]

67.      Fahey F, Zukotynski K, Capala J, Jadvar H, Dillehay G, Herscovitch P, Knight N, Pappas V, Sgouros G, Zalutsky MR, Wahl RL, Jacobsen E, Quinn DI, Carrasquillo JA, Vikram B, Larson S, O'Malley JP, Weber W, Srinivasan A, Bahnson RR, Brechbiel MW, Chen DY, Chen XS, Coleman N, Dicker AP, Goldenberg DM, Howell RW, Kaminskas E, Opanowski A, Pacak K, Pryma D, Speer TW, Srivastava SC, Tomlinson C, Valliant JF, Wessels BW, Wilbur DS, Gentile T, Wenzel-Lamb N, Ballinger A: “Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging”, J Nucl Med 55(2):337-48; 2014. (Abstract)

68.      Chung YY, Desai B, Ji L, Groshen SG, Jadvar H: “Comparative Performance of PET tracers in biochemical recurrence of prostate cancer: A critical analysis of literature”, Am J Nucl Med Mol Imaging 4(6):580-601; 2014. (Abstract) [NIH-NCI R01-CA1116101 Support]

69.      Jadvar H, Desai B, Conti PS: “Sodium 18F-Fluoride PET/CT of Bone, Joint and Other Disorders”, Semin Nucl Med 2015. (Invited Review Article)(In Press) [NIH-NCI R01-CA1116101 Support]

70.      Jadvar H, Chala S, Quinn D, Conti PS: One-year post-approval clinical experience with Radium-223 dichloride in patients with metastatic castrate-resistant prostate cancer”, Cancer Biotherm Radiopharm 2015. (In Review) ) [NIH-NCI R01-CA1116101 Support]

71.      Jadvar H: “Imaging cellular proliferation in prostate cancer with positron emission tomography”, Asia Oceania J Nucl Med Biol; 2015. (Invited Review Article)(In Press) [NIH-NCI R01-CA111610 and R21-CA142426 Support]

 

LETTER TO THE EDITOR and EDITORIALS (Peer-Reviewed)

 

1.         Jadvar H, Henderson RW: Comment on: "Hosoda K, Kawaguchi T, Ishii K, Minoshima S, Kohmora E. Comparison of conventional region of interest and statistical mapping method in brain single-photon emission computed tomography for prediction of hyperperfusion after carotid endarterectomy”,  Neurosurgery 57(1):41; 2005.

2.         Jadvar H: “Influence of trigger PSA and PSA kinetics on 11C- Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy”, J Nucl Med 51(3):498-99; 2010.

3.         Jadvar H: “Can choline PET tackle the challenge of imaging prostate cancer?”, Theranostics 2(3):331-332; 2012. [Invited Editorial] [NIH-NCI R01-CA1116101 and R21-CA142426 Support]

4.         Rohren EM, Dillehay GL, Jadvar H:  “SNMMI comment on ASCO 2013 Choosing Wisely recommendation on use of PET/CT in recurrent cancer surveillance”, J Nucl Med 55(5):699-700; 2014. 

5.         Jadvar H, Groshen SG, Quinn DI: “Association of overall survival with glycolytic activity of castrate resistant prostate cancer metastases”, Radiology 2015. (In Press)

 

CASE REPORTS (Peer-Reviewed)

 

1.        Jadvar H, Mindelzun RE, Jeffrey Jr RB: "Spontaneous intramural esophageal hematoma mimicking aortic dissection: treatment implications", Am J Roentgen AJR 169(e4); October 13, 1997. [Abstract]

2.        Jadvar H, Cham D, Gamie S, Henderson RW: "Fusion positron emission tomography-computed tomography demonstration of epidural metastases", Clin Nucl Med 29(1):39-40; 2004.

3.        Jadvar H, Bonyadlou S, Iagaru A, Colletti PM: "FDG PET-CT demonstration of Sjogren's sialoadenitis", Clin Nucl Med 30(10):698-9; 2005. [Abstract]

4.        Ho L, Seto J, Jadvar H: "Actinomycosis mimicking recurrent esophageal carcinoma on FDG PET-CT", Clin Nucl Med 31(10):646-7; 2006. [Abstract]

5.        Ho L, Henderson RW, Jadvar H: "Adenocarcinoma in an Indiana pouch on PET-CT", Clin Nucl Med 32(1):57-8; 2007. [Abstract]

6.        Desai B, Wafaa H, Quinn D, Jadvar H: “FDG PET/CT demonstration of pancreatic metastasis of prostate cancer”, Clin Nucl Med 36(10):961-2; 2011. [Abstract] [NIH-NCI R01-CA1116101 Support]

7.        Desai B, Gross M, Jadvar H: “Multimodality Imaging in Biochemical Recurrence of Prostate Cancer: Utility of 18F-NaF PET/CT in Early Detection of Metastasis”, Rev Esp Med Nucl Imagen Mol 31:231-2; 2012. [Abstract] [NIH-NCI R01-CA111610 Support]

8.        Lu D, Jadvar H, Go J, Henderson R, Boyko O, Grant E, Law M: “FDG-PET/MRI Fusion Demonstrating Cricoarytenoid Muscle Hypermetabolism Due to Contralateral True Vocal Cord Paralysis”, Rev Esp Med Nucl Imagen Mol 31(6):362-3; 2012. [Abstrcat]

CONFERENCE PROCEEDINGS FULL ARTICLES (Peer-Reviewed)

1.        Noh KH, Jadvar H, Jenkins JM: "Arrhythmia monitoring system on a personal computer", Proc IEEE 38th Ann Conf Eng Med Biol, Chicago, IL, 27: 126; 1985. (IEEE Cat. #85CH2244-2)

2.        Lin D, Jenkins JM, Wiesmeyer M, Jadvar H, Di Carlo L: "Analysis of time and frequency domain patterns of endocardial electrograms to distinguish ventricular tachycardia from sinus rhythm", Computers in Cardiology ,Boston, MA: IEEE Computer Society, pp. 171-174; 1986. (IEEE Cat.#87CH2476-0, ISBN 0-8186-0817-X)

3.        Jadvar H, Jenkins JM, Arzbaecher RC: "Computer ST segment measurement during transesophageal atrial pacing stress", Computers in Cardiology , Washington, DC: IEEE Computer Society, pp.227-229;1988. (IEEE Cat. #88CH2733-4, ISBN 0-8186-1949-X) [Article]

4.        Jadvar H, Jenkins JM, Arzbaecher RC: "Automated ECG analysis during esophageal pacing stress", Proc IEEE Eng Med Biol Soc10th Ann Int Conf , New Orleans, LA, 10(1):18-19; 1988. (IEEE Cat.#88CH2566-8)

5.        Jadvar H, Ripley K, Arzbaecher RC: "Power spectral, cepstral and Hartley analyses of intracardiac electrograms for detection of tachyarrhythmias", Computers in Cardiology, Jerusalem, Israel: IEEE Computer Society, pp.175-179; 1989. (IEEE Cat. #89CH2932-2, ISBN 0-8186-2114-1) [Article]

6.        Jadvar H, Benson DW Jr: "A stimulus artifact suppressor for esophageal pacing studies: design and clinical testing", Proc IEEE Eng Med Biol Soc 11th Ann Int Conf, Seattle, WA, 11(5):1401-1402;1989. (IEEE Cat. #89CH2770-6) [Article]

7.        Jadvar H, Bump TE, Arzbaecher RC: "Computer analysis of right ventricular pressure for improved discrimination of ventricular tachyarrhythmias", Computers in Cardiology, Chicago, IL: IEEE Computer Society, pp. 35-38; 1990.(IEEE Cat. 90CH3011-4, ISBN 0-8186-2225-3)(NIH Resident Research Award and University of Chicago Medical Alumni Prize) [Article]

8.        Jadvar H, Mina M: "Role of FDG PET in cancer detection", Proc Am Soc Nondestructive Testing (ASNT) Fall Conf, October 1997, Pittsburgh, PA, pp. 225-228; 1997. (ISBN 1-57117-068-5)

9.        Jadvar H, Segal GM: "Clinical applications and cost-effectiveness of PET in melanoma", Proc Int PET 9th Ann Conf, ICP, San Diego, CA, pp. 11-12; 1997.

10.     Kijewski MF, Moore SC, Jadvar H, Zimmerman RE, Müller SP: "Effects of SPECT collimation and system geometry on classification tasks related to Parkinson’s disease".  Proc IEEE Nucl Sci Symp Med Imag Conf, Lyon, France, IEEE Press: Piscataway, NJ; 2001.

11.     Jadvar H: "Pitfalls in oncologic FDG PET", ACNM Report, pp. 5-7; January 2001. [Article]

12.     Jadvar H: "Cardiac PET", ACNM Report, pp.5-6; August 2001. [Article]

13.     Jadvar H: "The role of PET in lung neoplasms", LARS 54th Ann Mid winter Rad Conf; pp. 41-43; January 2002.

14.     Jadvar H: "Head and neck malignancies: evaluation with PET", LARS 54th Ann Mid Winter Rad Conf; pp. 79-82; January 2002.

15.     Jadvar H: "Pediatric PET", ACNM Report, pp.4-5; April 2002. [Article]

16.     Jadvar H: "PET guiding infection management decisions", WebMD/Medscape SNM 49th Ann Meeting CME Summary, Los Angeles, CA; 2002. [Article]

17.     Jadvar H: "Utility of PET in staging prostate cancer", WebMD/Medscape SNM 49th Ann Meeting CME Summary, Los Angeles, CA; 2002. [Article]

18.     Jadvar H: "FDG PET imaging in infection and inflammation", ACNM Report; August 2002. [Article]

19.     Jadvar H: "Diagnostic imaging evaluation of prostate cancer with PET", ACNM Report; 2003. [Article]

20.     Jadvar H: "New tracers beckon for PET of prostate cancer", WebMD/Medscape SNM 50th Ann Meeting CME Summary, New Orleans, LA; 2003. [Article]

21.     Jadvar H: "Molecular imaging with PET: nuclear medicine's next frontier--molecular biology correlates of tumor", WebMD/Medscape SNM 50th Ann Meeting CME Summary, New Orleans, LA; 2003. [Article]

22.     Jadvar H: "FDG PET refining breast cancer management", WebMD/Medscape CME Summary; 2004. [Article]

23.     Jadvar H: "Update for oncologists: prostate cancer and the promise of PET", WebMD/Medscape CME Summary ; 2004. [Article]

24.     Jadvar H: "Molecular imaging: a new epoch for radiology -- and Healthcare", WebMD/Medscape RSNA 90th Ann Meeting CME Summary, Chicago, IL; 2004. [Article]

25.     Jadvar H: "New agents debut for positron emission tomography", WebMD/Medscape RSNA 90th Ann Meeting CME Summary, Chicago, IL; 2004. [Article]

26.     Jadvar H: "SPECT-CT: function meets morphology, again!", WebMD/Medscape RSNA 90th Ann Meeting CME Summary , Chicago, IL; 2004. [Article]

27.     Forouhar AS, Hove JR, Calvert C, Flores J, Jadvar H, Gharib M: "Electrocardiographic characterization of embryonic zebrafish", Proc IEEE Eng Med Biol Soc 26thAnn Int Conf , Vol.2, Iss., 1-5: 3615-3617;2004. [Abstract] (Research Collaboration with California Institute of Technology, Pasadena, CA)

28.     Jadvar H: "Prostate cancer and prognosis: role of PSA", WebMD/Medscape ASCO 1st Ann Meeting Multidisciplinary Prostate Cancer Symposium CME Summary, Orlando, FL; 2005. [Article]

29.     Jadvar H: "Imaging evaluation of prostate cancer", WebMD/Medscape ASCO 1st Ann Meeting Multidisciplinary Prostate Cancer Symposium CME Summary, Orlando, FL; 2005. [Article]

30.     Jadvar H: "Therapeutic solutions still lack comparative data", WebMD/Medscape ASCO1st Ann Meeting Multidisciplinary Prostate Cancer Symposium CME Summary, Orlando, FL; 2005. [Article]

31.     Jadvar H: "Molecular targeting and the biology of prostate cancer  ", WebMD/Medscape ASCO 1st Ann Meeting Multidisciplinary Prostate Cancer Symposium CME Summary ,Orlando, FL; 2005. [Article]

32.     Jadvar H: "Diagnostic horizons in PET: evaluation of prostate cancer", ACNP Scanner, March/April Issue, pp. 8-10; 2005. [Article]

33.     Jadvar H: "PET and PET-CT: expanding the scope of cardiovascular imaging", WebMD/Medscape SNM 52nd Ann Meeting CME Summary, Toronto, Ontario, Canada;2005. [Article]

34.     Jadvar H: "Molecular imaging update: personalized imaging for improved diagnosis and treatment decisions", WebMD/Medscape SNM 52nd Ann Meeting CME Summary, Toronto, Ontario, Canada; 2005. [Article]

35.     Jadvar H: "Refining pediatric cancer management through PET and PET-CT", WebMD/Medscape SNM 52nd Ann Meeting CME Summary, Toronto, Ontario, Canada;2005. [Article]

36.     Jadvar H:"Immunodiagnostics shape immunotherapeutics for improved cancer care", WebMD/Medscape SNM 52nd Ann Meeting CME Summary, Toronto, Ontario, Canada; 2005. [Article]

37.     Jadvar H: "The new oncology: cost-effectiveness and matchless impact of PET-CT in cancer management", WebMD/Medscape CME Summary; 2005. [Article]

38.     Jadvar H: "Hybrid Imaging, Part 1: Daybreak for a New Radiology", WebMD/Medscape RSNA 91st Ann Meeting CME Summary, Chicago, IL; 2005. [Article]

39.     Jadvar H: "Hybrid Imaging, Part 2: The Cancer Care Revolution", WebMD/Medscape RSNA 91st Ann Meeting  CME Summary, Chicago, IL; 2005. [Article]

40.     Jadvar H: "Cardiac Imaging Update, Part 1: Meet the "1-Stop-Shop" modality", WebMD/Medscape RSNA 91st Ann Meeting CME Summary, Chicago, IL; 2005. [Article]

41.     Jadvar H: "Cardiac Imaging Update, Part 2: CTA innovations", WebMD/Medscape RSNA 91stAnn Meeting CME Summary , Chicago, IL; 2005. [Article]

42.     Jadvar H: "Diagnostic role of PET in dementia", WebMD/Medscape CME Summary; 2006. [Article]

43.     Jadvar H: "Improving prognosis for patients with early prostate cancer: innovations in surgery, radiotherapy, and immunotherapy", WebMD/Medscape ASCO 2nd Ann Meeting Multidisciplinary Prostate Cancer Symposium CME Summary, San Francisco, CA; 2006. [Article]

44.     Jadvar H: "Using molecular pathways to select targeted therapies for prostate cancer", WebMD/Medscape ASCO 2nd Ann Meeting Multidisciplinary Prostate Cancer Symposium CME Summary, San Francisco, CA; 2006. [Article]

45.     Jadvar H: "Imaging of prostate cancer: many options, paltry progress", WebMD/Medscape ASCO 2nd Ann Meeting Multidisciplinary Prostate Cancer Symposium CME Summary, San Francisco, CA; 2006.  [Article]

46.     Jadvar H: "Balancing interventions with quality of life in advanced prostate cancer", WebMD/Medscape ASCO 2nd Ann Meeting Multidisciplinary Prostate Cancer Symposium CME Summary, San Francisco, CA; 2006.  [Article]

47.     Jadvar H: "Cardiac MRI: Still vying with CT for supremacy", WebMD/Medscape RSNA 92nd Ann Meeting CME Summary, Chicago, IL; 2007. [Article]

48.     Jadvar H: "Cardiac imaging update: Enhanced role for 64-Slice CT", WebMD/Medscape RSNA 92nd Ann Meeting CME Summary, Chicago, IL; 2007. [Article]

49.     Jadvar H: "Expanding applications for PET and PET/CT scanning", WebMD/Medscape RSNA 92nd Ann Meeting CME Summary, Chicago, IL; 2007. [Article]

50.     Jadvar H: "Milestones in molecular imaging", WebMD/Medscape RSNA 92nd Ann Meeting CME Summary, Chicago, IL; 2007. [Article]

51.     Jadvar H: "A New benchmark in renal diagnosis and prognosis: clinical applications of Tc-99m MAG3 renography", WebMD/Medscape CME Summary; 2007. [Article]

52.     Jadvar H, Shulkin BL: "PET and PET-CT in pediatric oncology", In: Categorical Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging, Wahl RL (ed.), The Radiological Society of North America, Oakbrook, IL; pp. 181-184; 2007.

53.     Jadvar H: "Expanding applications for PET-CT fusion imaging of children", WebMD/Medscape SNM 54th Ann Meeting CME Summary, Washington, DC; 2007. [Article]

54.     Jadvar H: "PET of breast cancer: detection and staging considerations", WebMD/Medscape SNM 54th Ann Meeting CME Summary, Washington, DC; 2007. [Article]

55.     Jadvar H: "New benchmarks in neuro-PET scanning", WebMD/Medscape SNM 54th Ann Meeting CME Summary, Washington, DC; 2007. [Article]

56.     Jadvar H: "Nuclear cardiology snapshot", WebMD/Medscape SNM 54th Ann Meeting CME Summary, Washington, DC; 2007. [Article]

57.     Jadvar H: "Why CT is a mainstay technology for assessing cardiac disease?”, WebMD/Medscape RSNA 93rd Ann Meeting CME Summary, Chicago, IL; 2008. [Article]

58.     Jadvar H: “Imaging of children: new options”, WebMD/Medscape RSNA 93rd Ann Meeting CME Summary, Chicago, IL; 2008. [Article]

59.     Jadvar H: “Burgeoning applications for PET-CT in oncology”, WebMD/Medscape RSNA 93rd Ann Meeting CME Summary, Chicago, IL; 2008. [Article]

60.     Jadvar H: “Imaging in the era of molecular medicine”, WebMD/Medscape RSNA 93rd Ann Meeting CME Summary, Chicago, IL; 2008. [Article]

CONFERENCE SCIENTIFIC PRESENTATION ABSTRACTS (Peer-Reviewed) 

1.        Jadvar H, Jenkins JM, Hsia P-W, Arzbaecher RC: "Computer processing of the electrocardiogram during transesophageal atrial pacing-induced stress", Engineering Foundation Computerized Interpretation of the Electrocardiogram XII, Palm Coast, FL, In: J Electrocardiology 20(Suppl):106-107; 1987. (Young Investigator Paper Competition Honorable Mention)

2.        Jadvar H: "Computer analysis of the electrocardiogram for detection of myocardial ischemia during transesophageal atrial pacing stress", Annals Biomed Eng 17(2):193-194; 1989. (Doctoral Dissertation Abstract)

3.        Benson DW Jr, Strasburger JF, Dembski M, Jadvar H: "Utility of a stimulus artifact suppressor for transesophageal pacing", Am Acad Pediatrics 31st Ann Conf, Chicago, IL, In: Am J Cardiol 64(5):417; 1989.

4.        Zabalgoitia-Reyes M, Gandhi DK, Skarzynski DJ, Larkin T, Molan P, Michael M, Jadvar H, Buinevicius RP, Mansour P, Talano JV: "Transesophageal echocardiography with transesophageal atrial pacing: a new method for detection of coronary artery disease", National Meeting of Am Fed for Clin Res ,Washington, DC, May 1990, In: Clin Res 38(2):507A; 1990.

5.        Arzbaecher RC, Ripley K, Guenneguez J, Jadvar H, Polikaitis A, Bump TE: "A combined monitor and pump controller for management of atrial arrhythmias in post surgical patients", Proc AAMI 26th Ann Meeting & Exhibition , Washington, DC, p. 49; 1991. (ISBN0-910275-54-8)

6.        Jadvar H, Segall GM, Norbash AM: "Unknown head and neck primary tumors: identification with F-18 FDG PET", Proc RSNA 82nd Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 201(P):239; 1996.

7.        Jadvar H, Johnson DL, Segall GM: "Diagnostic utility of 18-FDG PET in surgical management of patients with colon carcinoma: a prospective study", Proc Int PET 8th Ann Conf, ICP, Lake Buena Vista, FL, p. 20; 1996.

8.        Johnson DL, Jadvar H, Segall GM: "Use of positron emission tomography to identify regional and distant metastatic melanoma when traditional imaging studies are nondiagnostic", Proc Soc of Surg Onc 50th Ann Cancer Symposium , Chicago, IL, p. 18; 1997.

9.        Norbash AM, Jadvar H, Segall GM, Gilani S, Terris P:"Fluorodeoxyglucose PET imaging in discovering head and neck primary tumors and lymphadenopathy in the head and neck", Proc N Am Skull Base Soc 8th Ann Meeting, Little Rock, AR, In: Skull Base Surgery 7(Suppl.1):23-24;1997. (ISSN 1052-1453)

10.     Valk PE, Segall GM, Johnson DL, Pounds TR, Tesar RD, Jadvar H ,Abella-Columna E: "Cost-effectiveness of whole-body FDG PET imaging in metastatic melanoma", Proc SNM 44th Ann Meeting, San Antonio, TX, In: J Nucl Med 38(5 Suppl): 90P; 1997.

11.     Jadvar H, Phillips JR, Sullivan G, Lin V, Segall GM: "Radionuclide renograms impact the clinical management of patients with spinal cord injury", Proc Am Paraplegia Soc 43rd Ann Conf, Las Vegas, NV, In: J Spinal Cord Med 20(4):479-480; 1997.

12.     Jadvar H, Segall GM: "Comparison of FDG PET and CT in staging Hodgkin's lymphoma", Proc Int PET 9th Ann Conf, ICP, San Diego, CA, p. 21; 1997.

13.     Pichumani R, Jadvar H, Norbash AM, Drace J, Tovar M, Murray W: "Model-based finite-element three-dimensional segmentation and visualization of cervical spine CT images", Proc RSNA 83rd Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 205(P):168;1997.

14.     Jadvar H, Johnson DL, Abella-Columna E, Pounds TR, Valk PE, Segall GM: "Staging colorectal carcinoma with FDG PET at the time of initial diagnosis", Proc RSNA 83rd Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 205(P):399; 1997.

15.     Jadvar H, Johnson DL, Segall GM: "The impact of FDG PET on the clinical management of patients with malignant melanoma", Proc SNM 22nd Western Regional Meeting, Monterey, CA, In: Clin Nucl Med 23(7):487; 1998.

16.     Jadvar H, McDougall IR, Segall GM: "Diagnostic role of FDG PET in suspected recurrent thyroid carcinoma", Proc SNM 22nd Western Regional Meeting, Monterey, CA, In: Clin Nucl Med 23(7):489; 1998.

17.     Jadvar H, Johnson DL, Dolezal S, Segall GM: "Cost-effective management of cutaneous melanoma with FDG PET", Proc ACNP 24th Ann Meeting & Scientific Sessions, Las Vegas, NV, In: Clin Nucl Med 23(11):791; 1998. (ACNP Resident Research Competition Award)

18.     Jadvar H, Merchant N, Herfkens RJ, Li KCP: "Variceal hemorrhage risk prediction with cine phase-contrast MR portal venography in patients awaiting liver transplantation", Proc ARRS 98th Ann Meeting, San Francisco, CA, In: Am J Roentgenol AJR 170(4 Suppl):76; 1998.

19.     Jadvar H, McDougall IR, Segall GM: "FDG PET in suspected recurrent thyroid cancer", Proc Br Nuc Med Soc (BNMS) 26th Ann Meeting, Brighton, UK, In: Nucl Med Commun 19(4):385; 1998. (ISSN0143-3636)

20.     Jadvar H, Jeffrey SS, Cua DO, Birdwell RL, Strauss HW: "Value of combined imaging and use of gamma probe in intraoperative localization of sentinel lymph node in breast cancer", Proc SNM 45th Ann Meeting, Toronto, Ontario, Canada, In: J Nucl Med 39(5Suppl):24P;1998.(SNM-1998 Featured Research)

21.     Abella-Columna E, Pounds TR, Manolidis S, Jadvar H, Segall GM, Donald PJ, Valk PE: "Diagnosis and staging of recurrent head and neck cancer by whole-body FDG PET imaging", Proc SNM 45th Ann Meeting, Toronto, Ontario, Canada, In: J Nucl Med 39(5Suppl):122P;1998.

22.     Langleben D, Cortes A, Jadvar H, Kerkorian G, Portnoy O, Riddlehuber H, Austin G, Strauss HW: "Comparison of regional cerebral blood flow on and off methylphenidate (Ritalin) in boys with attention deficit hyperactivity disorder (ADHD)", Proc SNM 45th Ann Meeting, Toronto, Ontario, Canada, In: J Nucl Med 39(5 Suppl):203P; 1998.

23.     Langleben D, Jadvar H, Cortes A, Portnoy O, Kerkorian G, Riddlehuber H, Austin G, Strauss HW: "Methylphenidate (Ritalin) effect on the total brain uptake of Tc99m Ethyl Cysteinate Dimer (ECD) in boys with attention deficit hyperactivity disorder (ADHD) performing attention task", Proc SNM 45th Ann Meeting, Toronto, Ontario, Canada, In: J Nucl Med 39(5 Suppl):203P; 1998.

24.     Jeffrey SS, Jadvar H, Birdwell RL, Ikeda DM, Cua DO, Ansari Y, Strauss HW: "Multiple lymphatic drainage pathways in breast cancer and its implication for sentinel lymph node (SLN) biopsy and internal mammary (IM) lymph node biopsy or radiation", 1st Eur Breast Cancer Conf, Florence, Italy, Sept/Oct 1998, In: Eur J Cancer 34(5Suppl):S51;1998.

25.     Jadvar H, Parker JA, Fischman AJ: "Role of FDG PET in the evaluation of rare tumors", Proc Int PET 10th Ann Conf, ICP, Cambridge, MA, In: Clin Positron Imaging 1(4):239; 1998.

26.     Valk PE, Abella-Columna E, Pounds TR, Jadvar H, Segall GM: "Whole-body FDG PET imaging in recurrent head and neck cancer: effect on management cost", Proc SNM 46th Ann Meeting, Los Angeles, CA, In: J Nucl Med 40(5 Suppl):63P; 1999.

27.     Jadvar H, Fischman AJ: "Clinical impact of FDG PET on the management of patients with pancreatic carcinoma: comparison to CT and CA19-9 serology", Proc SNM 46th Ann Meeting, Los Angeles, CA, In: J Nucl Med 40(5 Suppl):104P; 1999.

28.     Krausz Y, Jeffrey SS, Ikeda DM, Jadvar H, Langleben D, Strauss HW: "Non-visualization of sentinel lymph node in patients with breast cancer", Proc SNM 46th Ann Meeting, Los Angeles, CA, In: J Nucl Med 40(5 Suppl):253P; 1999.

29.     Jadvar H, Shambye RB, Segall GM: "Physiologic source of intestinal FDG uptake: effect of atropine and sincalide", Proc Int PET 11th Ann Conf, ICP, Vancouver, BC, Canada, In: Clin Positron Imaging 2(6):318; 1999.

30.     Jadvar H: "Role of medical imaging in microgravity research", Proc Aerospace Med Assoc (AsMA) Ann Scientific Meeting, Houston, TX, In: Aviat Space Environ Med 71(3):304; 2000. (Aerospace Medicine Young Investigator Award Nominee)

31.     Jadvar H, Moore SC, Kijewski MF, Bonab A, Zimmerman RE, Fischman AJ: "Evaluation of SPECT imaging systems based on activity estimation in small brain structures", Proc SNM 47th Ann Meeting, St. Louis, MO, In: J Nucl Med 41(5 Suppl):180P; 2000.

32.     Tatlidil R, Jadvar H, Conti PS: "Utility of FDG-PET in the evaluation of residual or recurrent testicular carcinoma: comparison to CT and serum tumor markers", Proc RSNA 86th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 217(P):220;2000.(RSNA-2000 Featured Research)

33.     Tatlidil R, Jadvar H, Ramanna L, Conti PS: "Comparison of whole-body FDG-PET and Gallium-67 scintigraphy in restaging lymphoma", Proc RSNA 86th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 217(P):360; 2000. (RSNA-2000 Featured Research)

34.     Tatlidil R, Jadvar H, Conti PS: "Colonic uptake of [F-18]fluorodeoxyglucose: correlation with colonoscopy and histopathology", Proc RSNA 86th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 217(P):360; 2000. (RSNA-2000 Featured Research)

35.     Jadvar H, Tatlidil R, Conti PS: "Evaluation of recurrent gastric malignancy with FDG-PET", Proc RSNA 86th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 217(P):360;2000. (RSNA-2000 Featured Research)

36.     Jadvar H, Fischman AJ: "Diagnostic utility of FDG-PET inthe clinical management of patients with suspected recurrent pancreatic carcinoma after Whipple procedure", Proc Int PET 12th Ann Conf, ICP, Washington, DC, In: Clin Positron Imaging 3(4):156; 2000. [Abstract]

37.     Jadvar H, Fischman AJ: "Utility of FDG-PET in suspected recurrent pancreatic cancer", Proc 49th AUR Ann Meeting, Toronto, Ontario, Canada, p. 67; 2001.

38.     Jadvar H, Kulkarni M, Conti PS: "Evaluation of multiple myeloma with FDG-PET", Proc SNM 48th Ann Meeting, Toronto, Ontario, Canada, In: J Nucl Med 42(5 Suppl):31P; 2001.

39.     Jadvar H, Hovanessian L, Soni R, Lew M: "Subareolar injection sentinel lymph node mapping in breast cancer", Proc SNM 48th Ann Meeting, Toronto, Ontario, Canada, In: J Nucl Med 42(5Suppl):117P; 2001.

40.     Jadvar H, Tatlidil R, Conti PS: "FDG-PET in the evaluation of recurrent ovarian cancer", Proc SNM 48th Ann Meeting, Toronto, Ontario, Canada, In: J Nucl Med 42(5 Suppl):286P; 2001. [Article]

41.     Jadvar H, Bading JR, Yu X, Conti PS: "Dynamic FDG PET kinetic analysis of inflammation and cancer: preliminary results", Proc Ann Meeting of the Acad of Molecular Imaging, Orlando, FL, p. 61; 2001.

42.     Jadvar H, Conti PS: "FDG PET in the evaluation of women with cervical carcinoma", Proc RSNA 87th Scientific Assembly & Ann Meeting ,Chicago, IL, In: Radiology 221(P):386; 2001. (RSNA-2001 Featured Research)

43.     Conti PS, Bading JR, Alauddin MM, Fissekis JD, Berenji B, Hayles S, Jadvar H: "Tumor imaging with 2'-fluoro-5-11C-methyl-1- b-D-arabinofuranosyluracil (11C-FMAU): initial clinical studies", Proc SNM 49th Ann Meeting, Los Angeles, CA, In: J Nucl Med 43 (5 Suppl):26P;2002.

44.     Yu X, Zheng L, Jadvar H, Conti PS: "Assessment of non-invasive extraction of blood time activity for dynamic PET oncology", Proc SNM 49th Ann Meeting, Los Angeles, CA, In: J Nucl Med 43(5 Suppl):102P; 2002.

45.     Wang F, Lee K, Tubau J, Jadvar H, Lessel J, Tjoe M, Ramanna L, Henderson R: "Investigation of optimal imaging time for FDG myocardial viability studies using gamma camera coincidence detection", Proc SNM 49th Ann Meeting, Los Angeles, CA, In: J Nucl Med 43(5 Suppl):186P; 2002.

46.     Jadvar H, Bading JR, Yu X, Conti PS: "Kinetic analysis of inflammation and cancer with dynamic FDG PET", Proc SNM 49th Ann Meeting, Los Angeles, CA, In: J Nucl Med 43 (5 Suppl):271P; 2002.

47.     Jadvar H, Hovanessian L, Soni RA: "Sentinel lymph node mapping in breast cancer with subareolar lymphoscintigraphy", Proc SNM 49th Ann Meeting, Los Angeles, CA, In: J Nucl Med 43 (5Suppl):291P; 2002.

48.     Jadvar H, Conti PS: "Utility of [F-18]-FDG PET in multiple myeloma", Proc Ann Meeting of the Acad of Molecular Imaging, San Diego, CA, In: Mol Imaging Biol 4(4 Suppl 1):S46; 2002.

49.     Jadvar H, Kherbache HM, Conti PS: "FDG-PET in suspected recurrent and metastatic prostate carcinoma", Proc Ann Meeting of the Acad of Molecular Imaging, San Diego, CA, In: Mol Imaging Biol 4(4Suppl 1):S46; 2002.

50.     Jadvar H, Kherbache HM, Conti PS: "[F-18]-FDG PET in the evaluation of recurrent and metastatic renal cell carcinoma", Proc Ann Meeting of the Acad of Molecular Imaging, San Diego, CA, In: Mol Imaging Biol 4(4 Suppl. 1):S47; 2002.

51.     Wassef H, Jadvar H, Conti PS: "Clinical utility of FDG-PET in the evaluation of pancreatic adenocarcinoma", Proc RSNA 88th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 225(P):303; 2002.

52.     Jadvar H, Kherbache HM, Conti PS: "Utility of FDG-PET in suspected recurrent and metastatic prostate cancer", Proc RSNA 88th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 225(P):608; 2002. (RSNA-2002 Featured Research)

53.     Jadvar H, Epstein A, Conti PS: "Evaluation of suspected recurrent and metastatic breast carcinoma with 18F-FDG PET", Proc SNM 50th Ann Meeting, New Orleans, LA, In: J Nucl Med 44(5 Suppl):170P; 2003.

54.     Yu X, Li Z, Jadvar H, Conti PS: "Identification of malignant and benign lesions in dynamic PET oncology", Proc SNM 50th Ann Meeting, New Orleans, LA, In: J Nucl Med 44 (5 Suppl):263P; 2003.

55.     Jadvar H, Kherbache HM, Conti PS: "Diagnostic utility of FDG PET in metastatic and recurrent renal cell carcinoma", Proc SNM 50th Ann Meeting, New Orleans, LA, In: J Nucl Med 44 (5Suppl):404P; 2003.

56.     Jadvar H, Cham DK, Conti PS: "Diagnostic evaluation of esophageal carcinoma with [F-18]-FDG PET/CT", Proc Ann Meeting of the Acad of Molecular Imaging, Madrid, Spain, In: Mol Imaging Biol5(3):188;2003.

57.     Jadvar H, Chen X, Shahinian AH, Park R, Tohme M: "Autoradiography and microPET assessments of glucose metabolism in implanted murine xenografts of human prostate cancer", Proc Ann Meeting of the Acad of Molecular Imaging , Madrid, Spain, In: Mol Imaging Biol 5(3):137;2003.

58.     Chen X, Jadvar H, Pinski JK, Bading JR, Conti PS: "PET imaging of prostate cancer xenografts in bone", Proc Ann Meeting of the Soc for Molecular Imaging, San Francisco, CA, Mol Imaging 2(3):209; 2003.

59.     Jadvar H, Chen X, Pinski JK: "Biodistribution, autoradiography and microPET assessments of radiotracers in implanted murine xenografts of androgen-sensitive and androgen-independent human prostate cancer", Proc Ann Meeting of the Soc Molecular Imaging, San Francisco, CA, In: Mol Imaging 2(3):262; 2003.

60.     Gamie S, Jadvar H, Bonyadlou S, Rahmani S, Lee K: "Coincidence imaging with FDG in suspected recurrent and metastatic lung cancer", Proc 28th Ann Western Regional Meeting Soc Nucl Med Meeting, Anaheim, CA; 2003.

61.     Bonyadlou S, Jadvar H, Gamie S, Rahmani S, Lee K: "Coincidence imaging with FDG in suspected recurrent and metastatic colorectal carcinoma", Proc 28th Ann Western Regional Soc Nucl Med Meeting, Anaheim, CA; 2003.

62.     Bonyadlou S, Gamie S, Lee K, Jadvar H, Siegel M, Henderson RW, Ramanna L, Tubau J: "Differential effect on image quality and defect size in realistic phantoms with 180o and 360o acquisition orbits", Proc 28th Ann Western Regional Soc Nucl Med Meeting, Anaheim, CA; 2003.

63.     Jadvar H, Shahinian A, Conti PS: "Cellular metabolism and biodistribution of PET radiotracers in human prostate cancer", Proc RSNA 89th Scientific Assembly & Ann Meeting, Chicago, IL, p.194;2003.

64.     Jadvar H, Conti PS: "Fluorodeoxyglucose positron emission tomography in the evaluation of metastatic urinary bladder transitional cell carcinoma", Proc RSNA 89th Scientific Assembly & Ann Meeting, Chicago, IL, p. 400; 2003.

65.     Hoffmann U, Jadvar H, Dunn EJ, d’Othee BJ: "Is computed tomography-based coronary angiography ready for prime time? A meta-analysis", J Am Coll Cardiol 43(5 Suppl A):312A; 2004.

66.     Jadvar H, Conti PS:"[F-18]-FDG PET-CT evaluation of esophageal cancer", Proc SNM 51st Ann Meeting, Philadelphia, PA, In: J Nucl Med 45 (5Suppl):23P; 2004.

67.     Jadvar H, Shahinian A, Park R, Tohme M, Conti PS: "Effect of androgen on the glucose metabolism of prostate cancer: a microPET study", Proc SNM 51st Ann Meeting, Philadelphia, PA, In: J Nucl Med 45 (5Suppl):324P; 2004.

68.     Jadvar H, Shahinian A, Li X, Conti PS: "Androgen sensitivity of glucose metabolism in prostate cancer", Proc RSNA 90th Scientific Assembly & Ann Meeting, Chicago, IL, p. 154;2004.

69.     Jadvar H, Shahinian A, Li X, Park R, Tohme M, Conti PS: "[F-18]-fluorodeoxyglucose in metastatic prostate cancer: MiroPET and PET studies", Am Soc Clin Oncol 1st Multidisciplinary Prostate Cancer Symposium, Orlando, FL, p. 112; 2005.

70.     Iagaru A, Kundu R, Jocobstein J, Jadvar H, Nagle D: "Does FDG PET change the staging and management of anal cancer", Proc ACNP Ann Meeting & Scientific Sessions, San Diego, CA; 2005.

71.     Jadvar H, Conti PS:  " [F-18]-FDG PET and PET-CT in recurrent and metastatic cholangiocarcinoma", Proc SNM 52st Ann Meeting, Toronto, Ontario, Canada, In: J Nucl Med 46 (2Suppl):46P; 2005.

72.     Jadvar H, Li X, Shahinian A, Park R, Tohme M, Conti PS:  "Longitudinal microPET studies of tumor growth pattern and glucose metabolism in human prostate cancer murine xenografts" , Proc SNM 52st Ann Meeting, Toronto, Ontario, Canada, In: J Nucl Med 46 (2Suppl):385P; 2005.

73.     Jadvar H, Weinstein MC: "Decision tree sensitivity analysis of FDG PET in axillary staging ofT1/T2 clinical N0 breast cancer", Proc RSNA 89th Scientific Assembly & Ann Meeting, Chicago, IL, p. 655; 2005.

74.     Jadvar H, Xu A, Tumeh P, Pollock J, Nezami M, Conti PS: "Surveillance and management of lymphoma with serial FDG PET-CT", Proc RSNA 91st Scientific Assembly & Ann Meeting, Chicago, IL, p. 673; 2005.

75.     Jadvar H, Li X, Shahinian A, Park R, Tohme M, Conti PS: "Comparison of acetate and choline in mouse xenografts of human prostate cancer", Proc RSNA 91st Scientific Assembly & Ann Meeting , Chicago, IL, p. 675; 2005.

76.     Hoffmann U, Siebert U, Jadvar H, d'Othee BJ: "A systematic review of diagnostic accuracy of CT-based detection of significant coronary artery disease. A comparison of segment and patient based approach. American Heart Association; 2005.

77.     Jadvar H, Shahinian A, Park R, Conti PS: "Biodistribution of radiolabeled acetate in castrated and non-castrated mouse xenografts of human prostate cancer", Am Soc Clin Oncol 2nd Multidisciplinary Prostate Cancer Symposium, San Francisco, CA; p. 262; 2006.

78.     Ho L, Jadvar H, Quan V, Conti PS: "FDG PET-CT of bone metastases in breast cancer", Proc SNM 53rd Ann Meeting, San Diego, CA, In: J Nucl Med 47 (Suppl 1): 34P; 2006.

79.     Ho L, Jadvar H, Conti PS: "FDG PET-CT in the differential diagnosis of aspiration pneumonia and lung cancer", Proc SNM 53rd Ann Meeting, San Diego, CA, In: J Nucl Med 47 (Suppl 1): 337P; 2006.

80.     Huang BP, Jadvar H, Conti PS: "FDG PET-CT in acute leukemia", Proc SNM 53rd Ann Meeting, San Diego, CA, In: J Nucl Med 47 (Suppl 1): 52P; 2006.

81.     Huang BP, Jadvar H, Conti PS: "FDG PET-CT in chronic lymphoctyic leukemia", Proc SNM 53rd Ann Meeting, San Diego, CA, In: J Nucl Med 47 (Suppl 1): 481P; 2006.

82.     Jadvar H, Li X, Park R, Shahinian A, Conti PS: "Quantitative autoradiography of radiolabeled acetate in  mouse xenografts of human prostate cancer", Proc SNM 53rd Ann Meeting, San Diego, CA, In: J Nucl Med 47 (Suppl 1): 421P-422P; 2006. [NIH-NCI R01-CA111613 Support]

83.     Ho L, Jadvar H, Quan V, Conti PS: "FDG PET-CT of bone metastases in lymphoma",  Proc RSNA 92nd Scientific Assembly & Ann Meeting ,Chicago, IL, p. 329; 2006.

84.     Jadvar H, Li X, Park R, Shahinian A, Conti PS: "Early experience with quantitative autoradiography of radiolabeled choline in mouse xenografts of human prostate cancer", Proc RSNA 92nd Scientific Assembly & Ann Meeting , Chicago, IL; p. 816; 2006.

85.     Jadvar H, Li X, Shahinian A, Park R, Conti PS: "Androgen control of tumor growth and glucose metabolism in prostate cancer", Proc Soc Mol Imaging 5th Ann  Meeting, Hawaii, In Mol Imaging 5(3): 357; 2006.

86.     Jadvar H, Li X, Shahinian A, Gurbuz A, Conti PS: "MicroPET imaging of the effect of pharmacologic androgen ablation on growth and glucose metabolism of prostate cancer", Proc Am Soc Clin Oncol 3rd Multidisciplinary Prostate Cancer Symposium, Orlando, FL, p. 125; 2007.  (ISBN 978-1-932312-32-3)

87.     Xie JZ, Wang G-J, Jadvar H, Yow L, Vaska P, Ma Y, Humayun M: "PET assessment in retinal implant simulation tests", Proc Assoc Research Vision Ophthalmology Ann Meeting, Fort Lauderdale, FL; 2007.

88.     Ho, L, Henderson RW, Jadvar H, Conti PS, Mayer CL: "PET-CT evaluation of nodular thickening of bronchovascular bundles in the presence of malignant pleural disease", Proc Am Coll Nuclear Physicians 33rd Ann Meeting, San Antonio, TX; 2007.

89.     Iagaru A, Quan V, Jadvar H, Conti PS: "F-18 FDG PET/CT evaluation of response to chemotherapy in lymphoma: what is the optimal time for the first restaging scan?", Proc Am Coll Nuclear Physicians 33rd Ann Meeting, San Antonio, TX; 2007.

90.     Iagaru A, Quan V, Jadvar H, Conti PS: " Sentinel lymph node scintigraphy and F-18 FDG PET/CT in the management of breast cancer patients", Proc Am Coll Nuclear Physicians 33rd Ann Meeting, San Antonio, TX; 2007.

91.     Im M, Palmer S, Jadvar H, Qazi Y, Bahl P, Grant EG: "Duplex Doppler sonography: the clinical relevance of elevated renal vein velocity in kidney transplants", Proc RSNA 93rd Scientific Assembly & Ann Meeting , Chicago, IL, p.623; 2007.

92.     Jadvar H, Li X, Gurbuz A, Rona K, Shahinian A, Conti PS: "Temporal variation and effect of androgen on radiolabeled acetate uptake in human prostate cancer: an autoradiography study", Proc Soc Mol Imaging & Acad Mol Imaging Joint Conf, Providence, RI, p. 204; 2007. [NIH-NCI R01-CA111613 Support]

93.     Jadvar H, Ho L, Quan V, Mayer CL, Conti PS: "FDG PET-CT of normal human prostate gland", Soc Mol Imaging & Acad Mol Imaging Joint Conf, Providence, RI, p. 205; 2007. [NIH-NCI R01-CA111613 Support]

94.     Jadvar H: "Role of translational small animal imaging in prostate cancer", Biomed Eng Soc Ann Conf, Los Angeles, CA; 2007. [NIH-NCI R01-CA111613 Support]

95.     Modaressifar H, Kherbache H, Conti P, Jadvar H: “Regional distribution of metastatic lesions on PET-CT in patients with head and neck cancer: toward cancer-specific imaging protocols”, Proc SNM 55th Ann Meeting, New Orleans, LA, p. 138P; 2008.

96.     Jadvar H, Gurbuz A, Li X, Shahinian A, Conti P: “[14C]-Choline autoradiography of prostate cancer: effects of castration and uptake time interval”, Proc SNM 55th Ann Meeting, New Orleans, LA, p. 329P; 2008. [NIH-NCI R01-CA111613 Support]

97.     Jadvar H, Pinski J, Quinn D, Ye W, Groshen S, Henderson R, Conti P: “Concordance among FDG PET, CT and bone scan in men with metastatic prostate cancer”, Proc SNM 55th Ann Meeting, New Orleans, LA, p. 373P; 2008. [NIH-NCI R01-CA111613 Support]

98.     Nacca A, Jadvar H, Conti PS: “Hypoxia imaging with [F-18]-fluoromisonidazole (FMISO) PET: potential role in prostate cancer”, Proc SNM 55th Ann Meeting, New Orleans, LA, p.623; 2008. [NIH-NCI R01-CA111613 Support]

99.     Nacca A, Jadvar H, Park R, Li X, Cook J, Conti PS: “FDG and FMISO MicroPET imaging in a rodent model of human prostate cancer: initial observations”, Proc World Molecular Imaging Congress, Nice, France; 2008. [NIH-NCI R01-CA111613 Support]

100.  Modaressifar H, Shams S, Jadvar H: “Prediction of axillary nodal stage with morphologic and metabolic features of primary breast cancer on FDG PET-CT”, Proc SNM 56th Ann Meeting, Toronto, ON, Canada; p. 60P; 2009.

101.  Xie J, Wang JG, Yow L, Humayun M, Weiland J, Chader G, Jadvar H, Tsang SH, Fowler JS: “PET study of light and transcorneal electrical stimulation in humans”, Proc Assoc Research Vision Ophthalmology Ann Meeting, Fort Lauderdale, FL; 2009.

102.  Jadvar H, Pinski J, Quinn D, Carlon L, Ye W, Groshen S, Conti P: “PET/CT with FDG in metastatic prostate cancer: castrate-sensitive vs. castrate-resistant disease”, Proc SNM 56th Ann Meeting, Toronto, ON, Canada; p. 120P; 2009.  [NIH-NCI R01-CA111613 Support] (WebMD/Medscape SNM-2009 Featured Research)

103.  Kotak K, Tavakoli S, Jadvar H, Pashmforoush M: “Role of Ponsin in myocardial glucose metabolism and function: preliminary observations with molecular imaging”, NIH Multimodality Cardiovascular Molecular Imaging Symposium, Bethesda, MD, In J Nucl Med 50(4):662; 2009.

104.  Jadvar H, Shams S, Pourzand L, Ye W: “Normal segmental pattern of colonic metabolic activity”, Proc EANM Ann Meeting, Barcelona, Spain; 2009.

105.  Berenji GR, Jadvar H: “Diagnostic utility and impact of FDG PET in prostate cancer”, Proc Eur Soc Radiol, Vienna, Austria; 2010.

106.  Xie J, Wang JG, Yow L, Humayun M, Weiland J, Lazzi G, Cela CJ, Jadvar H, Fowler JS: “PET Study of Light and Transcorneal Electrical Stimulation in Humans”, Proc Assoc Research Vision Ophthalmology Ann Meeting, Fort Lauderdale, FL; 2010.

107.  Jadvar H, Desai BB, Conti PS, Dorff T, Groshen S, Pinski J, Quinn D, Ye W: “Detection of lymphadenopathy with FDG PET-CT in men with metastatic prostate cancer”, Proc SNM 57th Ann Meeting, Salt Lake City, UT, In: J Nucl Med 51(Supp 2):126P; 2010. [NIH-NCI R01-CA1116101 Support]

108.  Jadvar H, Desai B, Conti PS, Groshen S, Pinski J, Quinn D: “Clinical predictors of bone disease on FDG PET/CT in men with metastatic prostate cancer”, RSNA 96th Scientific Assembly & Ann Meeting, Chicago, IL, 2010. [NIH-NCI R01-CA1116101 Support]

109.  Lu D, Jadvar H, Go J, Henderson RW, Boyko OB, Grant EG: “Clinical utility of FDG PET and MRI hybrid fusion in the evaluation of patients with head and neck cancer”, RSNA 96th Scientific Assembly & Ann Meeting, Chicago, IL, 2010.

110.  Jadvar H, Desai B, Conti P, Dorff T, Gross M, Quinn D: ” Preliminary Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Metastatic Disease in Men with PSA Relapse after Treatment for Localized Primary Prostate Cancer”, Proc SNM 58th Ann Meeting, San Antonio, TX, J Nucl Med 52(Suppl. 1): p. 433P 2011. [NIH-NCI R01-CA1116101 Support]

111.  Jadvar H, Desai B, Quinn D, Dorff T, Pinski J, Conti P; Groshen S: ” Treatment Response Assessment of Metastatic Prostate Cancer with FDG PET/CT”, Proc SNM 58th Ann Meeting, San Antonio, TX, J Nucl Med 52(Suppl. 1): p. 431P; 2011. [NIH-NCI R01-CA1116101 Support] (SNM-2011 Featured Research)

112.  Quinn D, Desai B, Piatek C, Tang R, Hu J, Goldkorn A, Gross M, Hawes D, Jadvar H, Dorff T: ” Risk stratification and stage migration effect of novel imaging and biomarker technology in men with biochemical failure after local therapy for prostate cancer”, Proc Am Soc Clin Oncol Ann Meeting, Chicago, IL; 2011. [NIH-NCI R01-CA1116101 Support]

113.  Piatek C,  Desai B, Wei-Tsao D, Tang R, Acosta F, Pinski J, Dorff T, Goldkorn A, Jadvar H, Quinn D: ” RECIST 1.0 vs. 1.1: Implications for trial interpretation and design in advanced prostate cancer.”, Proc Am Soc Clin Oncol Ann Meeting, Chicago, IL; 2011. . [NIH-NCI R01-CA1116101 Support]

114.  Jadvar H, Desai B, Ji L, Quinn D, Dorff T, Gross M, Groshen S: “Association between 18F-NaF and FDG PET/CT and PSA in men with prostate cancer and biochemical relapse”, RSNA 97th Scientific Assembly & Ann Meeting, Chicago, IL, 2011. [NIH-NCI R01-CA1116101 Support]

115.  Jadvar H, Desai B, Ji L, Quinn D, Dorff T, Pinski J, Conti P, Groshen S: “Comparison of Imaging- and PSA-Based Treatment Response Criteria in Metastatic Prostate Cancer: A Preliminary Analysis”, RSNA 97th Scientific Assembly & Ann Meeting, Chicago, IL, 2011. [NIH-NCI R01-CA1116101 Support]

116. Desai B, Piatek C, Ji L, Groshen S, Quinn D, Jadvar H: “RECIST 1.0 vs. 1.1: Tumor Burden and Treatment Response Assessment in Metastatic Prostate Cancer”, World Molecular Imaging Congress, San Diego, CA, 2011. [NIH-NCI R01-CA1116101 Support]

117. Jadvar H, Yap L-P, Park R, Li Z, Chen K, Conti P: “Preclinical Evaluation of [F-18]-2’-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Mouse Models of Implanted Human Prostate Cancer Xenografts”, World Molecular Imaging Congress, San Diego, CA, 2011. [NIH-NCI R21- CA142426 Support]

118. Jadvar H, Desai B, Ji L, Conti PS, Dorff T, Pinski J, Quinn D, Groshen S: “Prognostic utility of FDG PET/CT in men with castrate-resistant metastatic prostate cancer”, Proc SNM 59th Ann Meeting, Miami Beach, FL, J Nucl Med 53(Suppl):116; 2012. [NIH-NCI R01-CA1116101 Support]

119. Jadvar H, Desai B, Ji L, Conti PS, Dorff T, Pinski J, Quinn D, Groshen S: “Impact of early treatment response assessment on prediction of overall survival in metastatic prostate cancer: RECIST 1.0 vs. PERCIST 1.0”, Proc SNM 59th Ann Meeting, Miami Beach, FL, J Nucl Med 53(Suppl):1403; 2012. [NIH-NCI R01-CA1116101 Support] [Top 10 Scientific Poster]

120.  Jadvar H, Desai B, Ji L, Groshen S, Conti P, Quinn D, Dorff T, Pinski J: “Prediction of time to hormonal treatment failure or death in men with castrate-sensitive metastatic prostate cancer”, RSNA 98th Scientific Assembly & Ann Meeting, Chicago, IL, 2012. [NIH-NCI R01-CA1116101 Support]

121.  Jadvar H, Desai B, Ji L, Groshen S, Conti P, Nayyar M, Dorff T, Pinski J, Quinn D: “Prognostic implication of changes on FDG PET/CT following early hormonal treatment in castrate-sensitive metastatic prostate cancer”, Proc SNM 59th Ann Meeting, Vancouver, BC, Canada; 2013.  [NIH-NCI R01-CA1116101 Support]

122.  Jadvar H, Desai B, Ji L, Groshen S, Yu C, Dorff T, Pinski J, Conti Ps, Quinn D: “RECIST 1.0, PERSICT 1.0, and PSA treatment response criteria in metastatic castrate-resistant prostate cancer”, RSNA 99th Scientific Assembly & Ann Meeting, Chicago. IL, 2013. [NIH-NCI R01-CA1116101 Support]

123.  Desai B, Allgood E, Cen S, Jadvar H: “Role 18F NaF PET-CT in tumor response assessment of skeletal metastases from prostate cancer: a preliminary analysis”, RSNA 99th Scientific Assembly & Ann Meeting, Chicago, IL, 2013.  [NIH-NCI R01-CA1116101 Support]

124.  Lampe A, Yu C, Desai B, Jadvar H: “PERCIST criteria for assessment of therapy response: a comprehensive review of existing literature”, Western Regional SNMMI Meeting, Pasadena, CA, 2013.

125.  Jadvar H, Desai B, Ji L, Groshn S: “Early treatment-related changes in bone lesion density and metabolism in castrate-resistant metastatic prostate cancer”, Proc SNMMI 60th Ann Meeting, St. Louis, MO; 2014.  [NIH-NCI R01-CA1116101 Support]

126.  Yu CY, Desai B, Ji L, Groshen S, Jadvar H: “Performance of PET tracers in biochemical recurrence of prostate cancer”, Proc SNMI 60th Ann Meeting, St. Louis, MO; 2014.  [NIH-NCI R01-CA1116101 Support]

127.  Conti PS, Challa S, Jadvar H, Pinski J, Gross M, Dorff T, Quinn D: “Initial post-approval clinical experience with Radium-223 dichloride in patients with prostate cancer”, Proc SNMMI 60th Ann Meeting, St. Louis, MO; 2014.

128.  Ballas L, Yoon J, Desai B, Jadvar H: “PSA Sensitivity of 18F-NaF PET for Detection of First Bone Metastases in Biochemical Recurrence of Prostate Cancer after Prostatectomy”, RSNA 99th Scientific Assembly & Ann Meeting, Chicago, IL, 2014. 

CONFERENCE EDUCATIONAL EXHIBIT ABSTRACTS (Peer-Reviewed)

1.       Merchant N, Jadvar H, Herfkens RJ: "Normal findings at cardiovascular MRI that mimic pathology", RSNA 82nd Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 201(P):484; 1996.

2.       Jadvar H, Strauss HW, Moon MR, Segall GM: "Nuclear cardiology: PET imaging of coronary artery disease", RSNA 83rd Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 205(P):673; 1997. (Category 1 CME Credit)

3.       Jadvar H, Johnson DL, Norbash AM, Segall GM: "Cancer detection with FDG PET", ARRS 98th Ann Meeting, San Francisco, CA, In: Am J Roentgen AJR 170(4 Suppl):190; 1998.

4.       Jadvar H, Segall GM: "False-negative and false-positive in FDG PET oncology", RSNA 84th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 209(P):528; 1998.

5.       Jadvar H: "Nuclear imaging in microgravity", SNM 46th Ann Meeting, Los Angeles, CA, In: J Nucl Med 40(5Suppl):322P; 1999. (Computer Exhibit) [Abstract]

6.       Jadvar H, Connolly LP, Treves ST, Fischman AJ: "PediPET: Diagnostic role of FDG PET in the evaluation of non-CNS pediatric tumors",  SNM 46th Ann Meeting, Los Angeles, CA, In: J Nucl Med 40(5 Suppl):203P; 1999.

7.       Jadvar H, Parker JA, Fischman AJ: "Role of FDG PET in the evaluation of rare tumors", RSNA 85th Scientific Assembly& Ann Meeting, Chicago, IL, In: Radiology 213(P):519; 1999.

8.       Saremi F, Jadvar H, Siegel ME: "Pharmacologic interventions in nuclear radiology: a review of indications, imaging protocols, and clinical results", RSNA 86th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 217(P):634; 2000. (Category 1CME Credit)

9.       Jadvar H, Connolly LP, Shulkin BL: "Role of FDG PET in pediatric oncology", Proc Ann Meeting of the Acad of Molecular Imaging, Orlando, FL, p. 65; 2001.

10.    Jadvar H, Saremi F, Patel T, Siegel ME: "Expecting the unexpected in nuclear radiology: an illustrative review of pathophysiological causes of atypical patterns and locations of radiotracer uptake", RSNA 87th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 221(P):672; 2001. (Category 1 CME Credit)

11.    Jadvar H, Conti PS: "Role of positron emission tomography in women's imaging: a review of indications and clinical results", RSNA 87th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 221(P):672; 2001. (Category 1 CME Credit)

12.    Jadvar H, Merchant N: "Imaging assessment of myocardial viability: a review of indications, protocols, and clinical results", RSNA 87th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 221(P):703; 2001. (Category 1 CME Credit)

13.    Jadvar H, Conti PS: "Inflammation and infection imaging with FDG-PET", RSNA 88th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 225(P):678; 2002. (Category 1CME Credit)

14.    Jadvar H, Lee KH: "Coincidence imaging with modified gamma cameras: physical principles and clinical utility", RSNA 88th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 225(P):678; 2002. (RSNA-2002 Certificate of Merit)

15.    Jadvar H, Learch TJ, Conti PS: "Multimodality imaging of musculoskeletal sarcoma", RSNA 88th Scientific Assembly & Ann Meeting, Chicago, IL, In: Radiology 225(P):681; 2002.

16.    Jadvar H, Grant D: "USC Molecular Imaging Center", RSNA 93rd Scientific Assembly & Ann Meeting, Chicago, IL, pp. 22, 868; 2007.

17.    Jadvar H, Pinski J, Quinn D, Conti PS: “Emerging role of positron emission tomography in prostate cancer”, SNM 55th Ann Meeting, New Orleans, LA, p. 177P; 2008. [NIH-NCI R01-CA111613 Support]

18.    Jadvar H, Wang Q, Tank A, Pinski J: “A Simple method for serial image-based monitoring of animal studies of novel treatments in human prostate cancer”, SNM 56th Ann Meeting, Toronto, ON, Canada; p. 182P; 2009.  [NIH-NCI R01-CA111613 Support]

19.    Jadvar H, Li Z, Conti PS: “Preclinical evaluation of F-18]-2’-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil ([F-18]-FMAU) PET in prostate cancer”, SNM 57th Ann Meeting, Salt Lake City, UT, In: J Nucl Med 51(Supp 2):190P; 2010.   [NIH-NCI R21- CA142426 Support]

20.    Jadvar H, Desai B: “A pictorial review of FDG PET/CT in prostate cancer”, RSNA 96th Scientific Assembly & Ann Meeting, Chicago, IL, 2010. [NIH-NCI R01-CA1116101 Support]

21.    Jadvar H, Desai B:18F-NaF PET/CT in Biochemical Recurrence of Prostate Cancer”, RSNA 97th Scientific Assembly & Ann Meeting, Chicago, IL, 2011. [NIH-NCI R01-CA1116101 Support]

22.    Sheth S, Hanks S, Bonyadlou S, Jadvar H: “Experience with Yttrium-90 Microsphere Treatment at the University of Southern California”, SNM 59th Ann Meeting, Miami Beach, FL, J Nucl Med 53(Suppl):1066;  2012. [3rd Place Top Poster]

23.    Jadvar H, Quinn D: “Alpha therapy of prostate cancer bone metastases with Radium-223 chloride”, RSNA 99th Scientific Assembly & Ann Meeting, Chicago, IL, 2013.

24.    Yu CY, Lampe A, Desai B, Jadvar H:  “Role of PET radiotracers for detection of locally recurrent and distant metastatic disease in patients with biochemically recurrent prostate cancer: a comprehensive review of existing literature”, Western Regional SNMMI Meeting, Pasadena, CA, 2013.

25.    Desai B, Jadvar H: “F18 NaF PET/CT in the assessment of metabolic bone disease and monitoring of response to therapy-preliminary results”, Western Regional SNMMI Meeting, Pasadena, CA, 2013.

26.    Desai B, Jadvar H: “The Utility of [F18]-Fluorodeoxyglucose PET/CT for Imaging Prostate Cancer: A Pictorial Guide”, RSNA 100th Scientific Assembly & Ann Meeting, Chicago, IL, 2014.

 

ELECTRONIC TEACHING CASES

 

1.       Jadvar H, Parker JA: "PET imaging of pulmonary artery sarcoma", Harvard Medical School Joint Program in Nuclear Medicine Electronic Teaching Cases; September 29, 1998. [Case]

2.       Jadvar H, Fischman AJ: "PET imaging of esophageal carcinoma", Harvard Medical School Joint Program in Nuclear Medicine Electronic Teaching Cases; November 17, 1998. [Case]

3.       Jadvar H, Fischman AJ: "PET imaging of pancreatic carcinoma", Harvard Medical School Joint Program in Nuclear Medicine Electronic Teaching Cases; February 2, 1999. [Case]

4.       Jadvar H, Fischman AJ: "PET imaging of pleural mesothelioma", Harvard Medical School Joint Program in Nuclear Medicine Electronic Teaching Cases; March 16, 1999. [Case]

TECHNICAL REPORTS

1.        Phillips B, Jadvar H, Lang MA: "Transesophageal atrial pacing: an emerging technique in noninvasive cardiology", Medical Electronics 18(6), Issue 108:20, 103-107; 1987.

2.        Jadvar H: "Advantages of transesophageal atrial pacing", Medical Electronics 20(5), Issue 119:156; 1989.

3.        Jadvar H: "Clinical applications of positron emission tomography", Iranian Med J 7(73):99-103; 2000. [Abstract]

4.        Jadvar H:Imaging Evaluation of Prostate Cancer with FDG-PET/CT”, SNM PET Center of Excellence Newsletter 7(3):1-2; 2010. [Article]

5.        Jadvar H: “Ga-68-DOTA TOCs, NOCs, and TATEs in Neuroendocrine Tumors”, SNM PET Center of Excellence Newsletter 9(2):1-2; 2012. [Article]

6.        Jadvar H: “Molecular Imaging of Prostate Cancer: Medical imaging, including PET radiotracer techniques, demonstrates promise in clinical care of prostate disease”, Advance for Imaging & Radiation Oncology 2012. [Article]

7.        Jadvar H: “The holy grail of imaging prostate cancer”, Diagnostic Imaging Europe 2013. [Article]

 

GOVERNANCE REPORTS

1.       Jadvar H: “Leadership and management: similarities and differences”, ACNP Scanner, Issue 1; 2008. [Article]

2.       Jadvar H: “ACNM Survey Results Summary”, ACNM Scanner, Issue 1; 2012. [Article]

3.       Jadvar H: “ACNM Letter from the President”, ACNM Scanner, Issue 1; April 2013. [Article]

4.       Bhujwalla Z, Neiman HL, Fahey FH, Schaefer PW, Jadvar H: “ACR-ACNM-ASNR-SNMMI-WMIS Joint Comment on Proposed Decision Memorandum for Positron Emission Tomography (FDG) for Solid Tumors (CAG00181R4); April 2013. [Article]

5.       Jadvar H: “President’s Report”, SNMMI PET Center of Excellence, August 2013. [Article]

6.       Jadvar H: “ACNM Letter from the President”, ACNM Scanner, Issue 2, August 2013. [Article]

7.          Jadvar H: “ACNM Comment on Proposed Decision CAG00431N Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease”, August 2013. [Article]

8.       Jadvar H: “ACNM Letter from the President”, ACNM Scanner, Issue 3, October 2013. [Article]

9.       Jadvar H: “President’s Report”, SNMMI PET Center of Excellence, December 2013. [Article]

10.    Jadvar H: “ACNM Letter from the President”, ACNM Scanner, Issue 1; February 2014. [Article]

11.    Jadvar H: “President’s Report”, SNMMI PET Center of Excellence, July 2014. [Article]

 

COMMENTS & VIEWPOINTS

1.        Jadvar H: "On Wisconsin...", IEEE Eng Med Biol 22(4):10; 2003.

2.        Jadvar H: “Is FDG PET-CT Useful in the Imaging Evaluation of Women with Inflammatory Breast Cancer?”, WebMD/Medscape View Point; 2009. [Article]

3.        Jadvar H: “Does Combined FDG PET-CT and STIR MRI have a Role in Mediastinal Nodal Staging in Lung Cancer?”, WebMD/Medscape View Point; 2009. [Article]

4.        Jadvar H: “Diagnostic Utility of Apparent Diffusion Coefficient Map with T2-weighted Images for Detection of Prostate Cancer”, WebMD/Medscape View Point; 2009. [Article]

5.        Jadvar H: “Can Magnetic Resonance Imaging and Spectroscopy Predict the Molecular Biology of Prostate Cancer?”, WebMD/Medscape View Point; 2009. [Article]

6.        Jadvar H: “Can Physiologic FDG Uptake by the Bowel Be Reduced?”,  WebMD/Medscape View Point; 2009. [Article]

7.        Jadvar H: “Can FDG PET-CT Predict Prognosis in Osteosarcoma?”,  WebMD/Medscape View Point; 2009. [Article] (Top 10 Most-Read Article by Radiologists - Medscape Radiology Edition, July 2009)

8.        Jadvar H: “Can PET-CT Accurately Characterize Adrenal Masses in Patients with Cancer?”, WebMD/Medscape View Point;  2009. [Article] (Top 10 Most-Read Article by Radiologists – Medscape Radiology Edition, July 2009)

9.        Jadvar H: “Is CT Colonography Cost-Effective for Screening Colon Cancer and Aortic Aneurysm in Medicare Population?”, WebMD/Medscape View Point; 2009. [Article]

10.     Jadvar H: “Is There a Role for FDG PET-CT in Imaging the Vulnerable Coronary Plaque?”, WebMD/Medscape View Point; 2009. [Article]

11.     Jadvar H: “Can FDG PET-CT Detect the Primary Cause of Ascites?”, WebMD/Medscape View Point; 2009. [Article]

12.     Jadvar H: “Are Radiologists Knowledgeable about management of Severe Contrast Material-Induced Allergic Reactions?”, WebMD/Medscape View Point; 2009. [Article]

13.     Jadvar H: “When to Image Vascular Inflammation with FDG PET-CT?”, WebMD/Medscape View Point; 2009. [Article]

14.     Jadvar H: “Physiologic Thymic FDG Uptake: What are the Incidence, Pattern, and Relationship to Treatment?”, WebMD/Medscape View Point; 2009. [Article]

15.     Jadvar H: “Do MRI Derived Parameters of the Prostate Gland Correlate with Histologic Parameters?”, WebMD/Medscape View Point; 2009. [Article]

16.     Jadvar H: “Is There a Need for Dedicated High-Resolution Head and Neck PET/CT?”, WebMD/Medscape View Point; 2009. [Article]

17.     Jadvar H: “I-123-MIBG Scintigraphy or FDG PET for the Imaging of Neuroblastoma?, WebMD/Medscape View Point; 2009. [Article]

18.     Jadvar H: “What is All the Noise About Time-of-Flight PET?”, WebMD/Medscape View Point; 2009. [Article]

19.     Jadvar H: “Is FDG-PET a Molecular Imaging Signature of Pheochromocytomas and Paragangliomas?”,  WebMD/Medscape View Point; 2009. [Article]

20.     Jadvar H: “Is Computer-Aided CT Volumetry of Pulmonary Nodules Useful in Lung Cancer Screening?, WebMD/Medscape View Point; 2009. [Article]

21.     Jadvar H: “Can a Cocktail of F-18-Fluoride and F-18-FDG PET-CT Scan Be Useful in Imaging for Malignancy?, WebMD/Medscape View Point; 2009. [Article]

22.     Jadvar H: “Addition of FDG PET to the Work-up for Surgical Resection of Colorectal Liver Metastases?”, WebMD/Medscape View Point; 2009. [Article]

23.     Jadvar H: “The Imaging Evaluation of Cognitive Impairment”, WebMD/Medscape View Point; 2009. [Article]

24.     Jadvar H: “How Do PSA Level and Kinetics Affect Rate of Tumor Detection by 11C-Choline PET/CT in Men with Biochemical Relapse After Radical Prostatectomy?”, WebMD/Medscape View Point; 2009. [Article]

25.     Jadvar H: “Can 11C PET/CT Detect Aggressive Primary Prostate Cancer?”, WebMD/Medscape View Point; 2009. [Article]

26.     Jadvar H: “Is MR Lymphography Cost-effective for Detection of Lymph Node Metastases in Prostate Cancer?”, WebMD/Medscape View Point; 2009. [Article]

27.     Jadvar H: “Can FDG Uptake Identify Clinically Significant Atherosclerotic Lesions?”, WebMD/Medscape View Point; 2009. [Article]

28.     Jadvar H: “What F-18 Choline PET Reveals About Osseous Metastatic Prostate Cancer”, WebMD/Medscape View Point; 2010. [Article]

29.     Jadvar H: “Cost-Effectiveness of Chest CT and FDG PET in Screening for Metastases in Head and Neck Cancer”, WebMD/Medscape View Point; 2010. [Article]

30.     Jadvar H: “Detection of Pulmonary Embolism: A Comparison Study of 3 Modalities”, WebMD/Medscape View Point; 2010. [Article]

31.     Jadvar H: “Evaluating Chest Pain: Which Imaging Approach Is Most Cost-Effective?, WebMD/Medscape View Point; 2010. [Article]

32.     Jadvar H: “FDG PET/CT: A Role in Monitoring Bone Metastases in Breast Cancer?”, WebMD/Medscape View Point; 2010. [Article]

33.     Jadvar H: “Prognostic Value of CT Coronary Angiography in Patients with Diabetes”, WebMD/Medscape View Point; 2010. [Article]

34.     Jadvar H: “Detection of Recurrent Prostate Cancer”, WebMD/Medscape View Point; 2010. [Article]

35.     Jadvar H: The Economics of Staging Non-small Cell Lung Cancer”, WebMD/Medscape View Point; 2010. [Article]

36.     Jadvar H: “Resting Brain Connectivity in Alzheimer Disease”, WebMD/Medscape View Point; 2010. [Article]

37.     Jadvar H: “Can FDG-PET/CT Detect Metastatic Infectious Foci in Patients With Bacteremia?”, WebMD/Medscape View Point; 2010. [Article]

38.     Jadvar H: “Predicting Pulmonary Embolism”, WebMD/Medscape View Point; 2010. [Article]

39.     Jadvar H: “When Can CT Colonography Replace Colonoscopy Surveillance?”, WebMD/Medscape View Point; 2011. [Article]

40.     Jadvar H: “Monitoring Bone Metastases With Diffusion-Weighted Imaging”, WebMD/Medscape View Point; 2011. [Article]

41.     Jadvar H: “MR Imaging of Body Fat Used in Lifestyle Intervention”, WebMD/Medscape View Point; 2011. [Article]

42.     Jadvar H: “PET/CT Enterography in Crohn Disease Evaluation”, WebMD/Medscape View Point; 2011. [Article]

43.     Jadvar H: “Emerging role of FDG PET in rheumatoid arthritis”, WebMD/Medscape View Point; 2011. [Article]

44.     Jadvar H: “Can PET/CT predict patients at risk for vascular events”. WebMD/Medscape View Point; 2011. [Article]

45.     Jadvar H: “Predicting response to chemotherapy in non-Hodgkin lymphoma”, WebMD/Medscape View Point; 2011. [Article]

46.     Jadvar H: “FDG uptake: can it predict survival in multiple myeloma?”, WebMD/Medscape View Point; 2011. [Article]

47.     Jadvar H: “Laxative-augmented contrast for imaging colorectal foci”, WebMD/Medscape View Point; 2011. [Article]

48.     Jadvar H: “Does periodontal FDG uptake predict carotid plaque?”, WebMD/Medscape View Point; 2011. [Article]

49.     Jadvar H: “CTA vs. calcium in predicting coronary events”, WebMD/Medscape View Point; 2011. [Article]

50.     Jadvar H: “MRI highly accurate in guiding prostate biopsy”, WebMD/Medscape View Point; 2011. [Article]

51.     Jadvar H: “Observations in healthy brain”, WebMD/Medscape View Point; 2011. [Article]

52.     Jadvar H: ”Predicting tumor response with PET scan”, WebMD/Medscape View Point; 2011. [Article]

53.     Jadvar H: “Image-guided sentinel node localization in prostate cancer”, WebMD/Medscape View Point; 2011. [Article]

54.     Jadvar H: “Colonography vs. colonoscopy for cancer detection”, WebMD/Medscape View Point; 2011. [Article]

55.     Jadvar H: “Differentiating central gland from benign prostatic hyperplasia”, WebMD/Medscape View Point; 2011. [Article]

56.     Jadvar H: “Performance of PET for adrenal mass: a meta-analysis”, WebMD/Medscape View Point; 2011. [Article]

57.     Jadvar H: “Best research developments in Radiology: 2011”, WebMD/Medscape View Point; 2011. [Article]

58.     Jadvar H: “Restrictive gadolinium guidelines halt NSF: study shows how”, WebMD/Medscape View Point; 2012. [Article]

59.     Jadvar H: “Molecular biology key in post-chemo breast MRI”, WebMD/Medscape View Point; 2012. [Article]

60.     Jadvar H: “What are the pulmonary embolus risk factors for children?”, WebMD/Medscape View Point; 2012. [Article]

61.     Jadvar H: US Useful, but MRS Still Needed for Obese Pediatric Liver Disease”, WebMD/Medscape View Point; 2012. [Article]

62.     Jadvar H: “Large Study Supports Prognostic Value of Cardiac MRI”, WebMD/Medscape View Point; 2012. [Article]

63.     Jadvar H:The Differential Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia”, WebMD/Medscape View Point; 2012. [Article]

64.     Jadvar H: Timing of Post-TX Imaging Key in Head, Neck Cancer”, WebMD/Medscape View Point; 2012. [Article]

65.     Jadvar H:Intra-articular Anesthetic for Shoulder MR Arthrography”, WebMD/Medscape View Point; 2012. [Article]

66.     Jadvar H: FDG PET for the Diagnosis of Cardiac Sarcoidosis”, WebMD/Medscape View Point; 2012. [Article]

67.     Jadvar H: “The diagnostic performance of CTC: does age matter?”, WebMD/Medscape View Point; 2012. [Article]

68.     Jadvar H: “What causes false-negative results on breast MRI studies”, WebMD/Medscape View Point; 2012. [Article]

69.     Jadvar H: “Unenhanced MRI for the detection of axillary lymph node metastasis”, WebMD/Medscape View Point; 2012. [Article]

70.     Jadvar H: “Radiologists’ recommendation for high cost imaging tests”, WebMD/Medscape View Point; 2012. [Article]

71.     Jadvar H: “Tibial stress injury severity grades, clinical severity, and time to healing”, WebMD/Medscape View Point; 2012. [Article]

72.     Jadvar H: “What are the prognostic value of pretreatment PET/CT in patients with invasive ductal breast cancer?”, WebMD/Medscape View Point; 2012. [Article]

73.     Jadvar H: “CT arthrography vs. MR arthrography for rotator cuff tendon tears”, WebMD/Medscape View Point; 2012. [Article]

74.     Jadvar H: “Diagnostic imaging in acute cholecystitis”, WebMD/Medscape View Point; 2012. [Article]

75.     Jadvar H: “The diagnostic accuracy of diffusion kurtosis MRI in grading gliomas”, WebMD/Medscape View Point; 2012. [Article]

76.     Jadvar H: “Cardiac CT angiography in predicting major adverse cardiac events”, WebMD/Medscape View Point; 2012. [Article]

77.     Jadvar H: “Evaluating testicular cancer: real-time sonoelastography vs. ultrasonography”, WebMD/Medscape View Point; 2012. [Article]

78.     Jadvar H: “Acute pulmonary embolism and short-term mortality”, WebMD/Medscape View Point; 2012. [Article]

79.     Jadvar H: “Can ‘body packing’ fool radiography?” WebMD/Medscape View Point; 2012. [Article]

80.     Jadvar H: “Whole body PET/CT for the assessment of distant malignancies”, WebMD/Medscape View Point; 2013. [Article]

81.     Jadvar H: “Ultrasonography vs. radiography for the detection of medial arterial calcification”, WebMD/Medscape View Point; 2013. [Article]

82.     Jadvar H: “Do all Medicare beneficiaries with NSCLC have access to PET?” WebMD/Medscape View Point; 2013. [Article]

83.     Jadvar H: “Risks of body CT scanning in young adults”, WebMD/Medscape View Point; 2013. [Article]

84.     Jadvar H: “How many vertebral body compression fractures go unreported?”, WebMD/Medscape View Point; 2013. [Article]

85.     Jadvar H: “Diagnostic accuracy of real-time CE-TRUS-guided prostate biopsy”, WebMD/Medscape View Point; 2013. [Article]

86.     Jadvar H: “Feasibility of simultaneous FDG PET/MRI of the heart”, WebMD/Medscape View Point; 2013. [Article]

87.     Jadvar H: “Is There a Role for Whole-Body DW MRI for Treatment Response Evaluation in Multiple Myeloma? ”, WebMD/Medscape View Point; 2014. [Article]

88.     Jadvar H: “Pretreatment MRI and prostate cancer recurrence”, WebMD/Medscape View Point; 2014. [Article]

89.     Jadvar H: “Imaging features and overall survival in castration-resistant prostate cancer”, WebMD/Medscape View Point; 2014. [Article]

90.     Jadvar H: “A better hybrid for imaging bone lesions?”, WebMD/Medscape View Point; 2014. [Article]

91.     Jadvar H: “Lung nodules on CT: which ones will spontaneously resolve?”, WebMD/Medscape View Point; 2014. [Article]

92.     Jadvar H: “The relationship between microinfarcts, Alzheimer disease, and cognitive function”, WebMD/Medscape View Point; 2014. [Article]

93.     Jadvar H: “PI-RADS vs Likert for prostate cancer”, WebMD/Medscape View Point; 2014. [Article]

94.     Jadvar H: “What is the prognostic value of pretreatment PET/CT in patients with invasive ductal breast cancer?”, WebMD/Medscape View Point; 2014. [Article]

95.     Jadvar H: “PET/MRI vs PET/CT for the detection of lung nodules”, WebMD/Medscape View Point; 2014. [Article]

96.     Jadvar H: “The radiogenomics of breast cancer”, WebMD/Medscape View Point; 2014.

97.     Jadvar H: “Emergency radiology services after Boston Marathon bombing”, WebMD/Medscape View Point; 2014.

98.     Jadvar H: “Pulmonary embolism in pregnancy: which imaging study?”, WebMD/Medscape View Point; 2014.

99.     Jadvar H: “Is there a role for whole-body DW MRI for treatment response evaluation in multiple myeloma”, WebMD/Medscape View Point; 2014.

100.  Jadvar H: “Transient ischemic dilatation and normal myocardial perfusion”, WebMD/Medscape View Point; 2014.

 

PODCAST

1.        Jadvar H: “What is PET?”; SNM PET Center of Excellence; 2010. [Podcast]

 

WEBINAR

1.       Jadvar H: ”Radium 223 alpha therapy for metastatic prostate cancer”; Society of Nuclear Medicine and Molecular Imaging; January 15, 2014.

 


BIOGRAPHY – may not be as updated as the online version


·       H Jadvar - Brief Biography

·       H Jadvar - NIH Format Biography

·      H Jadvar - CV PDF

·      H. Jadvar Profile (University of Michigan BME Alumni)

·      H. Jadvar - Google Scholar

·      H. Jadvar - Web of Science


Internet Links


(Last update: December 15, 2014)